{"gene":"MAPK11","run_date":"2026-06-10T02:59:50","timeline":{"discoveries":[{"year":1996,"finding":"MAPK11 (p38beta) is a MAP kinase containing a TGY dual phosphorylation site required for kinase activity; it is preferentially activated by MKK6 (rather than MKK3/MKK4), and shows strong substrate preference for ATF2 (~20-fold greater transactivation than p38alpha), with kinetic studies showing ~180-fold greater activity than p38 on ATF2.","method":"In vitro kinase assays, in vivo transfection, two-dimensional phosphopeptide analysis, reporter gene assays, site-directed mutagenesis of TGY motif","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinase assays with mutagenesis, multiple substrate analyses, replicated by independent characterization paper","pmids":["8663524"],"is_preprint":false},{"year":1997,"finding":"MAPK11 (p38-2/p38beta) is activated by stress signals and proinflammatory cytokines; MEK6 is its preferred upstream kinase; it phosphorylates ATF2 and Sap-1a but not Elk1 with increased transcriptional activity; steady-state kinetics suggest a sequential kinetic mechanism.","method":"In vitro kinase assays, steady-state kinetic analysis, two-dimensional phosphopeptide analysis, reporter gene assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal methods (kinetics, phosphopeptide mapping, reporter assays), corroborated by [8663524]","pmids":["9235954"],"is_preprint":false},{"year":1998,"finding":"MAPK11/SAPK2/p38 directly activates MSK1 in vitro; stress-induced activation of MSK1 in cells is blocked by SB203580 (a SAPK2/p38 inhibitor); MSK1 phosphorylates CREB at Ser133, suggesting SAPK2/p38 mediates stress-induced CREB activation via MSK1.","method":"In vitro kinase assay, pharmacological inhibition (SB203580), cell-based kinase activation assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro reconstitution plus pharmacological validation in multiple cell lines","pmids":["9687510"],"is_preprint":false},{"year":1998,"finding":"MAPK11 (p38-2) is required for bradykinin-induced slow inhibition of N-type calcium current in NG108-15 cells; BK selectively activates p38-2, and SB203580 suppresses this inhibition, placing p38-2 downstream of G13 and Rac1/Cdc42 in this pathway.","method":"Electrophysiology, pharmacological inhibition (SB203580), kinase activity assays","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional epistasis with pharmacological inhibitor and isoform-selective activation data, single lab","pmids":["9412491"],"is_preprint":false},{"year":1998,"finding":"Expression of p38beta attenuates SB202190-induced apoptosis and cell death induced by Fas ligation and UV irradiation, whereas p38alpha expression mildly induces cell death; SB202190 induces apoptosis through CPP32-like caspases, and this is blocked by p38beta overexpression, indicating p38beta and p38alpha have opposing roles in apoptosis.","method":"Overexpression of p38 isoforms, caspase activity assays, nuclear condensation and DNA fragmentation assays, Bcl-2 overexpression rescue","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic overexpression with functional readout, multiple apoptosis assays, single lab","pmids":["9632706"],"is_preprint":false},{"year":1998,"finding":"SAPK2/p38 (including MAPK11) mediates oxidative stress-induced actin cytoskeletal reorganization into stress fibers and focal adhesion formation in endothelial cells via phosphorylation of HSP27 through MAPKAP kinase-2/3; SAPK2 inhibition by SB203580 blocks membrane blebbing during H2O2-induced apoptosis; expression of non-phosphorylatable HSP27 prevents F-actin accumulation and blebbing.","method":"Pharmacological inhibition (SB203580, PD098059), expression of mutant HSP27, F-actin staining, caspase assay, DNA fragmentation","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple cell lines, genetic (mutant HSP27) and pharmacological approaches, multiple mechanistic readouts","pmids":["9832563"],"is_preprint":false},{"year":1999,"finding":"SAPK2/p38 pathway activation mediates oxidant-induced inhibition of insulin-stimulated glucose transport in skeletal muscle cells; inhibiting p38 with SB202190 or SB203580 restores insulin-stimulated glucose transport but not glycogen synthesis, establishing p38 as a cross-talk node between stress and insulin signaling.","method":"Glucose transport assay, glycogen synthesis assay, in vitro kinase assays, pharmacological inhibition (SB202190, SB203580, wortmannin, PD98059)","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional assays with selective inhibitors, multiple concentrations, single lab","pmids":["10593919"],"is_preprint":false},{"year":1999,"finding":"SAPK2/p38 controls actin dynamics by phosphorylating HSP27 via MAPKAP kinase-2/3; this pathway mediates VEGF-induced actin reorganization and cell migration in vascular endothelial cells.","method":"Pharmacological inhibition, phosphorylation assays, cell migration assays","journal":"Biochemical Society symposium","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — supported by multiple linked studies; this is a review-type summary but consolidates experimental findings from primary work","pmids":["10207622"],"is_preprint":false},{"year":1999,"finding":"A short-lived protein upstream of SAPK2/p38 constitutes a heat-shock-specific sensing mechanism; cycloheximide progressively desensitizes cells to heat-shock-induced SAPK2/p38 activation, and MG132 (proteasome inhibitor) constitutively activates SAPK2/p38, suggesting proteasomal degradation controls this upstream activator.","method":"Pharmacological treatments (cycloheximide, MG132, SB203580), kinase activity assays, heat shock desensitization experiments","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple pharmacological tools, single lab, mechanistic pathway placement","pmids":["10608813"],"is_preprint":false},{"year":2000,"finding":"VEGFR2-mediated SAPK2/p38 activation drives actin polymerization and cell migration in endothelial cells; VEGFR2 (not VEGFR1) is specifically responsible for SAPK2/p38 activation; the pathway is independent of FAK phosphorylation, which instead depends on HSP90.","method":"VEGFR1/VEGFR2-selective cell lines, neutralizing antibody, pharmacological inhibition (SB203580, geldanamycin), HSP90 overexpression rescue, migration assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — receptor-selective cell lines, genetic rescue, multiple pathway inhibitors, replicated across labs","pmids":["10744763"],"is_preprint":false},{"year":2000,"finding":"p38alpha and p38beta are constitutively active in adult mouse brain; p38alpha localizes to dendrites and cytoplasmic/nuclear regions of neurons, whereas p38beta is preferentially localized to the nucleus of neurons.","method":"Biochemical fractionation, immunohistochemistry, in vivo kinase activity assays","journal":"Journal of neuroscience research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization by immunohistochemistry with biochemical fractionation, single lab","pmids":["10820433"],"is_preprint":false},{"year":2000,"finding":"Cyclic mechanical stretch of bladder smooth muscle cells activates p38 SAPK2 and JNK/SAPK pathways independently of ERK-MAPK; p38 SAPK2 pathway contributes to stretch-stimulated DNA synthesis and HB-EGF gene expression, independently of ErbB2 and AT1 receptor pathways.","method":"Pharmacological inhibition (SB203580, PD98059), kinase activity assays, DNA synthesis measurement, gene expression analysis","journal":"American journal of physiology. Cell physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple inhibitors, independent pathway validation, single lab","pmids":["11003596"],"is_preprint":false},{"year":2001,"finding":"Tumor cell adhesion to E-selectin-expressing endothelium activates SAPK2/p38 in HT-29 tumor cells, leading to HSP27 phosphorylation and transendothelial migration; blocking SAPK2/p38 with SB203580 or dominant-negative SAPK2/p38 inhibits transendothelial migration but not cell adhesion.","method":"Dominant-negative MAPK11 expression, pharmacological inhibition (SB203580), phospho-HSP27 western blot, transendothelial migration assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic (dominant-negative) and pharmacological approaches with functional readout, multiple cell lines","pmids":["11448946"],"is_preprint":false},{"year":2001,"finding":"p38beta (but not p38alpha) protects rat mesangial cells from TNF-alpha-induced apoptosis; p38beta does not affect TNF-alpha-induced NF-kappaB nuclear translocation.","method":"Adenovirus-mediated gene transfer of p38beta/dominant-negative p38beta, cell viability assay, NF-kappaB translocation assay, pharmacological inhibition (SB203580)","journal":"Journal of cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — isoform-specific genetic overexpression and dominant-negative, single lab","pmids":["11500933"],"is_preprint":false},{"year":2003,"finding":"SAPK2/p38 mediates gap junction closure in astrocytes in response to IL-1beta and hyperosmotic stress; upon activation, p38/SAPK2 translocates from nucleus to cytoplasm; p38 inhibition with SB203580 reverses inhibition of gap junction communication; PKC acts as a distal effector of p38 in this pathway.","method":"Pharmacological inhibition (SB203580), immunocytochemistry for p38 localization, dye coupling assay, PKC inhibitor experiments","journal":"Glia","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional localization assay tied to pathway output, pharmacological tools, single lab","pmids":["15048855"],"is_preprint":false},{"year":2004,"finding":"VEGFR2 phosphorylation at Tyr1214 is required for VEGF-induced activation of Cdc42 and subsequently SAPK2/p38 and MAPKAP kinase-2, leading to actin remodeling into stress fibers; dominant-negative Cdc42 inhibits SAPK2/p38 activation; RhoA and Rac are not involved in SAPK2/p38-mediated actin reorganization.","method":"Site-directed mutagenesis of VEGFR2 Y1214F, dominant-negative/constitutively active Cdc42 constructs, GTPase activity assay, pharmacological inhibition (SB203580), actin staining","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1 / Strong — site-directed mutagenesis of upstream receptor, multiple genetic tools (dominant-negative and constitutively active GTPases), mechanistic pathway placement","pmids":["14724572"],"is_preprint":false},{"year":2004,"finding":"SAPK2b/p38beta (MAPK11) specifically binds and phosphorylates glycogen synthase at Ser644, Ser652, Thr718 and Ser724 in vitro; p38beta serves as a priming kinase that enables GSK-3 to phosphorylate Ser640 and inhibit glycogen synthase activity; p38beta shows greater affinity for glycogen synthase than p38alpha, p38gamma, or p38delta.","method":"In vitro kinase assay, substrate binding assay, phosphopeptide mapping, isoform comparison, co-incubation with GSK-3","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro phosphorylation, phosphosite mapping, priming kinase mechanism demonstrated","pmids":["14680475"],"is_preprint":false},{"year":2004,"finding":"p38alpha (but not p38beta) promotes Fas-mediated apoptosis by inhibiting phosphorylation and presence of c-FLIPS in DISC to promote caspase-8 activation; both p38alpha and p38beta contribute to mitochondrial Bax localization and inhibition of Bad phosphorylation.","method":"Overexpression and translational silencing of p38alpha/p38beta, DISC immunoprecipitation, FACS analysis, caspase activity, western blot","journal":"Journal of cell science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — isoform-specific genetic approaches, multiple apoptotic pathway readouts, single lab","pmids":["15572410"],"is_preprint":false},{"year":2005,"finding":"p38beta (MAPK11) knockout mice are viable and show normal p38alpha activation, ERK1/2, JNK, MAPKAP-K2, and MSK1 activation, normal p38-dependent immediate-early gene transcription, normal T-cell development, and normal LPS-induced cytokine production; p38beta is dispensable for inflammatory disease progression in TNFDeltaARE mice, indicating p38alpha is the predominant isoform in immune responses.","method":"Genetic knockout, kinase activity assays, cytokine ELISA, TNFDeltaARE cross, disease scoring","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — germline knockout with comprehensive multi-pathway and multi-disease phenotyping","pmids":["16287858"],"is_preprint":false},{"year":2005,"finding":"Spinal p38beta (MAPK11) in microglia (not p38alpha in neurons) mediates tissue injury-induced hyperalgesia; intrathecal antisense knockdown of p38beta but not p38alpha prevents formalin-evoked nocifensive behavior and substance P-induced hyperalgesia, and blocks spinal p38 phosphorylation.","method":"Isoform-specific antisense oligonucleotides, behavioral pain assays (formalin, substance P), immunohistochemistry for isoform localization, phospho-p38 western blot","journal":"Journal of neurochemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — isoform-selective genetic knockdown in vivo with behavioral and biochemical readouts","pmids":["15748168"],"is_preprint":false},{"year":2005,"finding":"p38beta MAPK (MAPK11) mediates CO-induced caveolin-1 expression in smooth muscle cells; p38beta-/- fibroblasts fail to upregulate caveolin-1 in response to CO; p38beta downregulates ERK1/2, which represses caveolin-1 transcription; caveolin-1 is required for the antiproliferative effect of CO.","method":"p38beta knockout cells, p38beta gene transfer rescue, CO treatment, ERK1/2 western blot, caveolin-1 expression, cell proliferation assay","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — knockout plus genetic rescue, mechanistic pathway identification, in vivo and in vitro confirmation","pmids":["16051704"],"is_preprint":false},{"year":2005,"finding":"MAPK11/14 (p38 MAPK) activation is required for EGF-stimulated cytotrophoblast differentiation and syncytium formation; pharmacological inhibition (SB203580/SB202190) blocks spontaneous and EGF-stimulated beta-hCG secretion and cytotrophoblast fusion.","method":"Pharmacological inhibition (SB203580, SB202190), beta-hCG ELISA, BrdU proliferation assay, villous explant culture","journal":"Biology of reproduction","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological approach with functional readouts, cannot fully distinguish p38alpha from p38beta contribution","pmids":["16120828"],"is_preprint":false},{"year":2006,"finding":"Phosphorylation of VEGFR-2 at Tyr1214 recruits adapter Nck and Src-family kinase Fyn (but not c-Src) to VEGFR-2; Fyn activates PAK-2 and is required for SAPK2/p38 but not FAK activation; this Fyn-Nck-PAK2 complex drives SAPK2/p38 activation, stress fiber formation, and endothelial cell migration.","method":"Immunoprecipitation with HA-tagged VEGFR-2 mutants, chemical and dominant-negative inhibitors of Fyn/c-Src, stress fiber staining, migration assays, PAK-2 phosphorylation assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — receptor mutants, reciprocal co-IP, multiple genetic/chemical inhibitors, two orthogonal readouts","pmids":["16966330"],"is_preprint":false},{"year":2006,"finding":"p38beta MAPK is required for Ca2+-induced PKCdelta/eta-mediated E2F1 proteasomal degradation during keratinocyte differentiation; dominant-negative p38beta but not p38alpha blocks E2F1 downregulation in this context.","method":"Dominant-negative p38beta expression, pharmacological PKC inhibitors, western blot for E2F1, differentiation assays","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — isoform-specific dominant-negative, single lab, single method for p38beta specificity","pmids":["16116476"],"is_preprint":false},{"year":2007,"finding":"Chemical genetics demonstrates that specific inhibition of p38alpha (not p38beta) is necessary and sufficient for anti-inflammatory efficacy; p38beta knock-in (T106M) mice are resistant to pharmacological p38 inhibition of LPS-induced TNF production; p38beta knockout mice show normal inflammatory responses.","method":"Chemical genetics knock-in mice (T106M mutation), p38beta knockout mice, LPS challenge, collagen antibody-induced arthritis model, TNF ELISA","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — two independent genetic approaches (knock-in and knockout) with in vivo disease models","pmids":["17855341"],"is_preprint":false},{"year":2008,"finding":"p38alpha-PRAK complex localizes to the nucleus while p38beta-PRAK complex localizes exclusively to the cytosol; two residues (Asp145/Leu156 in p38alpha vs. Gly145/Val156 in p38beta) determine the distinct localization; nuclear import (not export) is the determining step; Leu156 of p38alpha interacts with the NLS of PRAK; nuclear localization of PRAK is required for its antiproliferative function.","method":"Chimeric and point mutants of p38alpha/p38beta, subcellular fractionation, random mutagenesis, nuclear import assays, co-localization, NIH3T3 proliferation assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — mutagenesis identifying specific residues, structural modeling, functional consequence established","pmids":["18268017"],"is_preprint":false},{"year":2008,"finding":"TGFbeta-induced alpha-smooth muscle cell actin (alphaSMA) expression in renal proximal tubular cells requires p38beta (not p38alpha) MAPK and is mediated via MKK6 (not MKK3); dominant-negative p38beta and dominant-negative MKK6b block TGFbeta-induced alphaSMA; Smad7 and dominant-negative Smad3 also block this effect.","method":"Adenoviral expression of dominant-negative p38alpha/p38beta and dominant-negative MKK3/MKK6, western blot for alphaSMA, alphaSMA promoter-luciferase reporter, phospho-specific antibodies","journal":"Nephrology, dialysis, transplantation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — isoform-specific dominant-negatives with pathway dissection, single lab","pmids":["18192325"],"is_preprint":false},{"year":2009,"finding":"The crystal structure of human p38beta was determined at 2.05 Å resolution; structural comparison with p38alpha revealed that differences in relative orientation of N- and C-terminal domains reduce the size of the ATP-binding pocket in p38beta compared to p38alpha.","method":"X-ray crystallography (PDB: 3gc8, 3gc9 for p38beta C162S and C119S/C162S mutants; 3gc7 for p38alpha C162S)","journal":"Acta crystallographica. Section D, Biological crystallography","confidence":"High","confidence_rationale":"Tier 1 / Strong — high-resolution crystal structure with functional implications for inhibitor selectivity","pmids":["19622861"],"is_preprint":false},{"year":2010,"finding":"During hypoxia/reoxygenation in cardiomyocytes, p38alpha phosphorylates p53 at Ser15 leading to mitochondrial p53 translocation and apoptosis; p53 in turn suppresses p38beta activity; estrogen inhibits this p38alpha-p53 axis and preserves p38beta pro-survival activity.","method":"Pharmacological inhibition of p38alpha/p38beta, p53 inhibition, ROS measurement, cardiomyocyte apoptosis assays, western blot for phospho-p53, mitochondrial fractionation","journal":"Cardiovascular research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological tools with isoform selectivity, multiple functional readouts, single lab","pmids":["20724307"],"is_preprint":false},{"year":2011,"finding":"p38alpha and p38beta together are required for mouse embryonic development; combined deletion causes cardiovascular abnormalities at midgestation absent in single knockouts; p38beta cannot fully substitute for p38alpha functions during embryogenesis (assessed by knock-in of p38beta under p38alpha promoter).","method":"Double knockout mice, p38beta knock-in under p38alpha promoter, embryonic phenotype analysis, cardiac gene expression analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic models including double KO and knock-in, developmental phenotype with molecular analysis","pmids":["21768366"],"is_preprint":false},{"year":2011,"finding":"p38beta (MAPK11) promotes phosphorylation of Raptor at Ser863 and Ser771 upon arsenite treatment, thereby activating mTORC1; arsenite induces direct interaction between p38beta and Raptor; this pathway is specific to arsenite and not activated by insulin, nutrients, anisomycin, or H2O2.","method":"Co-immunoprecipitation, in vitro kinase assay, phospho-Raptor western blot, mTORC1 activity assays, stimulus specificity comparison","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro phosphorylation, co-IP demonstrating physical interaction, multiple stimuli controls","pmids":["21757713"],"is_preprint":false},{"year":2011,"finding":"p38beta activity and STAT pathway are concurrently activated by neuropoietic cytokines (CNTF/LIF) in sympathetic neurons; p38beta overexpression in absence of cytokines stimulates cholinergic marker expression; p38beta-/- neurons show impaired neurotransmitter switch in vitro; stellate ganglion of p38beta-/- mice shows loss of cholinergic properties in vivo.","method":"p38beta knockout neurons, p38alpha/p38beta overexpression, dominant-negative p38, cytokine treatment, cholinergic marker expression, in vivo stellate ganglion analysis","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout confirmed in vitro and in vivo, overexpression gain-of-function, isoform specificity established","pmids":["21865449"],"is_preprint":false},{"year":2012,"finding":"p38beta (MAPK11) specifically phosphorylates C/EBPβ at Thr-188 (a site not phosphorylated by p38alpha), enabling C/EBPβ binding to the atrogin1/MAFbx promoter and upregulating this ubiquitin ligase; C/EBPβ T188A mutant acts as dominant-negative inhibitor of atrogin1/MAFbx upregulation; p38beta-mediated muscle catabolism is abrogated in C/EBPβ-null mice.","method":"Tryptic phosphopeptide mapping, ChIP assay, site-directed mutagenesis of C/EBPβ T188A, siRNA knockdown, constitutively active p38alpha/beta expression, C/EBPβ knockout mice, in vivo muscle injection","journal":"Skeletal muscle","confidence":"High","confidence_rationale":"Tier 1 / Strong — phosphosite mapping, ChIP, mutagenesis, and in vivo knockout all converge on same mechanistic conclusion","pmids":["23046544"],"is_preprint":false},{"year":2012,"finding":"TGF-beta1 activates p38alpha (proapoptotic) and shifts VEGF signaling from p38beta (prosurvival) to p38alpha in endothelial cells; gene silencing of p38alpha blocks TGF-beta1-induced apoptosis; downregulation of p38beta or p38gamma causes massive apoptosis.","method":"Gene silencing (siRNA) of p38 isoforms, apoptosis assays, isoform-specific phosphorylation analysis","journal":"Molecular cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — isoform-specific siRNA with multiple apoptotic readouts, single lab","pmids":["22454"],"is_preprint":false},{"year":2013,"finding":"SOCE-induced AMPK (alpha1 isoform) activates p38beta MAPK, which directly phosphorylates STIM1 on serine residues, inhibiting SOCE (acting as an 'off switch'); knockdown of p38beta (but not other p38 isoforms) prevents PAR-1-mediated STIM1 phosphorylation and potentiates Ca2+ entry.","method":"siRNA knockdown of p38 isoforms and AMPKα1, STIM1 phosphorylation assay, Ca2+ entry measurements, permeability assays, AICAR treatment","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — isoform-specific knockdown, direct phosphorylation shown, functional consequence established with multiple approaches","pmids":["23625915"],"is_preprint":false},{"year":2013,"finding":"Integrin-linked kinase (ILK) selectively forms cytoplasmic complexes with p38beta (not other p38 isoforms); ILK knockdown reduces p38beta protein levels post-translationally via the 26S proteasome; ILK-p38beta signaling regulates Hsp27 phosphorylation, actin cytoskeletal organization, and Rac1-dependent bladder cancer cell migration.","method":"siRNA knockdown of ILK/p38beta, co-immunoprecipitation, bimolecular fluorescence complementation, proximity ligation assay, proteasome inhibitor rescue (MG132), Hsp27 phosphorylation, migration assay","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP plus orthogonal proximity ligation assay, proteasomal mechanism with rescue, functional consequence","pmids":["23435415"],"is_preprint":false},{"year":2014,"finding":"p38beta (MAPK11) possesses an intrinsic autophosphorylation activity; a 13-residue region comprising part of the alpha-G helix and MAPK insert triggers this activity; when inserted into p38alpha, this fragment renders it spontaneously active in vitro and in mammalian cells; an interaction between the N-terminus and C-terminal extension suppresses this autophosphorylation in vivo.","method":"In vitro autophosphorylation assay, chimeric construct generation, mammalian cell expression, mutagenesis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with mutagenesis, domain-swap experiments confirmed in cells","pmids":["25006254"],"is_preprint":false},{"year":2014,"finding":"p38beta-mediated p38 activity in breast cancer cells upregulates MCP-1 secretion, which activates osteoclast differentiation and bone resorption; shRNA knockdown of p38beta reduces osteoclast differentiation in vitro and bone destruction in SCID mouse models.","method":"shRNA knockdown of p38beta, conditioned media osteoclast differentiation assay, MCP-1 ELISA, SCID mouse bone metastasis model","journal":"Biochimie","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic knockdown with in vitro and in vivo readouts, single lab","pmids":["25066918"],"is_preprint":false},{"year":2016,"finding":"p38beta MAPK mediates activin A/ActRIIB-induced skeletal muscle catabolism via C/EBPβ activation; siRNA knockdown of p38beta (not p38alpha) abolishes activin A catabolic effects; muscle-specific p38beta knockout mice are protected from activin A-induced muscle catabolism in vivo.","method":"siRNA knockdown, muscle-specific p38beta knockout mice, C2C12 myotube atrophy assays, ubiquitin ligase expression, LC3-II western blot, p38 inhibitor (SB202190)","journal":"Journal of cachexia, sarcopenia and muscle","confidence":"High","confidence_rationale":"Tier 2 / Strong — isoform-specific siRNA and conditional knockout mice with in vitro and in vivo concordance","pmids":["27897407"],"is_preprint":false},{"year":2016,"finding":"p38beta in mitochondria of cardiomyocytes phosphorylates MnSOD at Thr79 and Ser106; estrogen promotes mitochondrial localization of active p38beta and augments MnSOD activity; point mutation of T79/S106 to alanine abolishes MnSOD antioxidant function; physical interaction between p38beta and MnSOD demonstrated by co-IP.","method":"In vitro kinase assay, co-immunoprecipitation, mitochondrial fractionation, point mutagenesis of MnSOD T79A/S106A, MnSOD activity assay, ROS measurement, in vivo I/R model in OVX and ER-null mice","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro kinase assay with phosphosite identification, co-IP, mutagenesis abolishing function, in vivo validation","pmids":["27930699"],"is_preprint":false},{"year":2016,"finding":"p38beta MAPK self-regulates basal activity through autophosphorylation at multiple sites in its MAPK insert (T241, S261) in addition to the activating T180 site; T241 phosphorylation reduces autophosphorylation in trans; S261 phosphorylation reduces activity of T180-phosphorylated p38beta; T241 is phosphorylated in vivo in bone and muscle tissues and correlates with myogenic differentiation.","method":"In vitro autophosphorylation assay, mass spectrometry, site-directed mutagenesis, mammalian cell expression, tissue phosphorylation analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro autophosphorylation with mutagenesis at multiple sites, MS-confirmed sites, in vivo tissue validation","pmids":["26976637"],"is_preprint":false},{"year":2017,"finding":"MAPK11 (p38beta) is a positive modulator of mutant huntingtin (mHTT) protein levels via its kinase activity; MAPK11 knockout significantly rescues disease-relevant behavioral phenotypes in a knockin HD mouse model; the effect is mHTT-dependent, suggesting a feedback mechanism.","method":"MAPK11 knockout mice (HD knockin background), cell-based mHTT level assays, kinase-dead mutant, behavioral phenotyping","journal":"Cell research","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout in vivo with behavioral rescue, kinase-activity dependence shown","pmids":["29151587"],"is_preprint":false},{"year":2017,"finding":"p38beta (MAPK11) mediates GLP-1R agonist exenatide-induced microglial POMC/beta-endorphin expression via a PKA-p38beta-CREB signaling cascade; siRNA knockdown of p38beta (not p38alpha) abolishes exenatide-induced p38 phosphorylation and POMC expression; intrathecal siRNA/p38beta blocks exenatide-induced spinal beta-endorphin expression and mechanical antiallodynia.","method":"siRNA isoform-specific knockdown (p38alpha vs. p38beta), intracellular cAMP assay, western blot for p-PKA/p-p38/p-CREB, POMC/beta-endorphin ELISA, intrathecal injection in neuropathic rats","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 2 / Strong — isoform-specific genetic knockdown in vitro and in vivo with concordant biochemical and behavioral readouts","pmids":["28202578"],"is_preprint":false},{"year":2018,"finding":"p38beta MAPK (MAPK11) mediates ULK1-dependent autophagy activation in cachectic skeletal muscle of tumor-bearing mice; p38beta activates transcription factor C/EBPβ to upregulate LC3b and Gabarapl1; p38beta phosphorylates ULK1 at S555; active ULK1 forms a complex with p38beta in myocytes; muscle-specific p38beta knockout abrogates tumor-induced autophagy, UPP activation, and muscle wasting.","method":"Muscle-specific p38beta knockout mice, LLC tumor model, ULK1 phosphorylation assays, co-immunoprecipitation (ULK1-p38beta complex), C/EBPβ activation assays, autophagy markers (LC3b, Gabarapl1), p38alpha pharmacological comparison","journal":"Cell stress","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional knockout with in vivo tumor model, co-IP demonstrating complex, phosphorylation site identification, multiple pathway readouts","pmids":["31225455"],"is_preprint":false},{"year":2020,"finding":"Upon cancer-induced TLR4 activation in skeletal muscle, p38beta MAPK phosphorylates Ser-12 on p300, stimulating C/EBPβ acetylation and muscle wasting; nilotinib preferentially inhibits p38beta over p38alpha and abrogates this pathway; systemic nilotinib at 0.5 mg/kg/day alleviates muscle wasting and prolongs survival in tumor-bearing mice.","method":"Genetic knockdown, p300 phosphorylation assay, C/EBPβ acetylation assay, catabolic gene expression, tumor-bearing mouse model, nilotinib treatment, survival analysis","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — isoform-specific genetic and pharmacological approaches, phosphorylation of specific substrate residue identified, in vivo rescue","pmids":["33355181"],"is_preprint":false},{"year":2021,"finding":"MAPK11/14 (p38 MAPK) directly phosphorylates SNX27 at Ser51 in response to multiple stressors (starvation, LPS, IL-6, EGF), altering its cargo-binding pocket conformation and reducing interactions with cargo proteins, thereby inhibiting endocytic recycling and promoting receptor lysosomal degradation.","method":"Phosphoproteomics, in vitro kinase assay, mutagenesis of SNX27 S51, cargo binding assays, endocytic recycling assays, multiple stress stimuli","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro phosphorylation, mutagenesis of phosphosite, structural consequence (conformation change), functional readout (recycling inhibition)","pmids":["33605979"],"is_preprint":false},{"year":2023,"finding":"p38beta (MAPK11) is a critical host factor for SARS-CoV-2 replication, functioning at a step after viral mRNA expression; genetic screening, proteomics, and phosphoproteomics identified putative host and viral p38beta substrates in SARS-CoV-2-infected cells; most identified host p38beta substrates have intrinsic antiviral activities.","method":"Quantitative genetic screening, genomics, proteomics, phosphoproteomics, multiple cell line validation","journal":"mBio","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multi-omic approach with genetic validation, but substrate phosphorylation described as 'putative' without full biochemical validation of individual substrates","pmids":["37345956"],"is_preprint":false},{"year":2023,"finding":"Phosphorylated MAPK11 (p38beta) physically interacts with RUNX2 and sustains RUNX2 protein stability in clear cell renal cell carcinoma cells; P-MAPK11 and RUNX2 co-immunoprecipitate; high RUNX2 expression can neutralize functional degradation of MAPK11; both promote ccRCC cell proliferation and migration.","method":"Co-immunoprecipitation, cycloheximide chase assay (RUNX2 half-life), siRNA knockdown, colony formation, EdU assay, transwell migration","journal":"Journal of cellular and molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP demonstrating interaction, protein stability assay, single lab","pmids":["37525479"],"is_preprint":false}],"current_model":"MAPK11 (p38beta) is a stress- and cytokine-activated MAP kinase with a TGY dual-phosphorylation activation motif that is preferentially activated by MKK6; unlike p38alpha, it possesses intrinsic autophosphorylation activity mediated by its alpha-G helix/MAPK insert region, and self-regulates through additional autophosphorylation at inhibitory sites T241 and S261; it has a distinct substrate specificity from p38alpha—most notably it uniquely phosphorylates C/EBPβ at Thr-188 to drive atrogin1/MAFbx-mediated muscle catabolism, phosphorylates Raptor at Ser863/Ser771 to activate mTORC1 in arsenite-stressed cells, phosphorylates STIM1 to suppress Ca2+ entry, phosphorylates glycogen synthase as a priming kinase for GSK-3, phosphorylates MnSOD at T79/S106 in mitochondria for antioxidant defense, phosphorylates p300 at Ser-12 to drive cancer-induced muscle wasting, and phosphorylates SNX27 at Ser51 to inhibit endocytic recycling; its p38beta-PRAK complex is excluded from the nucleus (unlike p38alpha-PRAK) due to residues Gly145/Val156; it plays pro-survival roles in multiple cell types (mesangial cells, cardiomyocytes, astrocytes, endothelial cells) contrasting with pro-apoptotic p38alpha, promotes cholinergic transdifferentiation of sympathetic neurons, mediates spinal microglial beta-endorphin expression in pain processing, acts as a host dependency factor for SARS-CoV-2 replication, and modulates mutant huntingtin levels in Huntington's disease models."},"narrative":{"mechanistic_narrative":"MAPK11 (p38beta) is a stress- and cytokine-activated MAP kinase that requires dual phosphorylation of its TGY motif for catalysis and is preferentially activated by MKK6/MEK6, with strong transactivation of substrates such as ATF2 and Sap-1a [PMID:8663524, PMID:9235954]. It is distinguished from its paralog p38alpha both structurally and functionally: its crystal structure reveals a constricted ATP-binding pocket relative to p38alpha [PMID:19622861], and it possesses an intrinsic autophosphorylation activity localized to a 13-residue alpha-G helix/MAPK insert region that is restrained in vivo by an N-terminal/C-terminal interaction and by inhibitory autophosphorylation at T241 and S261 in addition to the activating T180 site [PMID:25006254, PMID:26976637]. p38beta executes a distinct substrate program: it acts as a priming kinase that phosphorylates glycogen synthase to enable GSK-3 [PMID:14680475], phosphorylates Raptor at Ser863/Ser771 to activate mTORC1 selectively under arsenite stress [PMID:21757713], phosphorylates STIM1 to switch off store-operated Ca2+ entry [PMID:23625915], phosphorylates mitochondrial MnSOD at Thr79/Ser106 to sustain antioxidant defense [PMID:27930699], and phosphorylates SNX27 at Ser51 to remodel its cargo pocket and inhibit endocytic recycling [PMID:33605979]. A dominant theme is its control of skeletal muscle catabolism, where it uniquely phosphorylates C/EBPbeta at Thr-188 to drive atrogin1/MAFbx expression, phosphorylates p300 at Ser-12 to promote C/EBPbeta acetylation, and phosphorylates ULK1 at Ser555 to activate autophagy, collectively mediating activin A-, tumor-, and cachexia-associated muscle wasting [PMID:23046544, PMID:31225455, PMID:33355181]. In contrast to the pro-apoptotic actions of p38alpha, p38beta is broadly pro-survival across mesangial cells, cardiomyocytes, and endothelial cells [PMID:11500933, PMID:20724307, PMID:22454], and its signaling output is spatially restricted because the p38beta-PRAK complex is excluded from the nucleus via residues Gly145/Val156 [PMID:18268017]. It also drives HSP27-dependent actin remodeling and migration downstream of VEGFR2 [PMID:10744763, PMID:16966330], mediates cholinergic transdifferentiation of sympathetic neurons and spinal microglial beta-endorphin expression in pain processing [PMID:21865449, PMID:28202578], modulates mutant huntingtin levels [PMID:29151587], and serves as a host dependency factor for SARS-CoV-2 replication [PMID:37345956]. Genetic knockout establishes that p38beta is dispensable for inflammatory cytokine responses, where p38alpha predominates [PMID:16287858, PMID:17855341].","teleology":[{"year":1996,"claim":"Established MAPK11 as a bona fide stress-activated MAP kinase with a defined activation requirement and a substrate preference distinct from p38alpha, answering whether the new isoform was catalytically and regulatorily independent.","evidence":"In vitro kinase assays, TGY-motif mutagenesis, phosphopeptide mapping and reporter assays defining MKK6 as preferred activator and ATF2/Sap-1a as preferred substrates","pmids":["8663524","9235954"],"confidence":"High","gaps":["Did not resolve in vivo substrate repertoire beyond transcription factors","Physiological context of MKK6 selectivity not addressed"]},{"year":1998,"claim":"Placed p38/MAPK11 upstream of MSK1-CREB signaling, linking stress kinase activity to transcriptional output via a downstream effector kinase.","evidence":"In vitro reconstitution of MSK1 activation plus SB203580 inhibition in cells, with MSK1 phosphorylating CREB Ser133","pmids":["9687510"],"confidence":"High","gaps":["Inhibitor does not distinguish p38alpha from p38beta","Isoform-specific contribution to CREB activation not isolated"]},{"year":1998,"claim":"Revealed an isoform divergence in cell-fate control, showing p38beta is pro-survival/anti-apoptotic where p38alpha is pro-apoptotic.","evidence":"Isoform overexpression with caspase, nuclear condensation, DNA fragmentation and Bcl-2 rescue assays under Fas/UV challenge","pmids":["9632706"],"confidence":"Medium","gaps":["Overexpression may not reflect endogenous stoichiometry","Molecular substrates mediating survival not identified"]},{"year":1999,"claim":"Connected the p38/MAPK11 pathway to cytoskeletal remodeling and migration through HSP27 phosphorylation via MAPKAPK2/3, defining a non-transcriptional output.","evidence":"SB203580 inhibition, non-phosphorylatable HSP27 mutants, F-actin staining and migration assays in endothelial cells","pmids":["9832563","10207622"],"confidence":"High","gaps":["Pharmacology and pathway summaries do not isolate p38beta from p38alpha","Direct p38beta-HSP27 axis not demonstrated"]},{"year":2000,"claim":"Mapped the receptor-proximal pathway driving p38-dependent actin remodeling, identifying VEGFR2 as the specific receptor input.","evidence":"VEGFR1/VEGFR2-selective cell lines, neutralizing antibodies, SB203580 and HSP90 rescue with migration assays","pmids":["10744763"],"confidence":"High","gaps":["Isoform identity of activated p38 not resolved","Direct kinase-substrate steps downstream of VEGFR2 not fully reconstituted"]},{"year":2004,"claim":"Dissected the upstream cascade from VEGFR2-Tyr1214 through Cdc42 to p38, and later through a Fyn-Nck-PAK2 module, establishing how a receptor selectively engages p38-MAPKAPK2 actin signaling.","evidence":"VEGFR2 Y1214F mutagenesis, dominant-negative/constitutively active Cdc42, reciprocal co-IP and chemical/dominant-negative Fyn inhibition with stress-fiber and migration readouts","pmids":["14724572","16966330"],"confidence":"High","gaps":["p38beta-specific role within this VEGFR2 cascade not separated from p38alpha","Direct effector phosphorylation by the relevant isoform not shown"]},{"year":2004,"claim":"Identified the first p38beta-preferred metabolic substrate, showing it functions as a priming kinase for GSK-3 on glycogen synthase.","evidence":"In vitro kinase and substrate-binding assays, phosphopeptide mapping, isoform affinity comparison and co-incubation with GSK-3","pmids":["14680475"],"confidence":"High","gaps":["In vivo relevance to glycogen metabolism not established","Upstream activator in this context not defined"]},{"year":2005,"claim":"Genetic knockout resolved the physiological essentiality of MAPK11, showing it is dispensable for inflammation and immune development, with p38alpha predominant.","evidence":"Germline p38beta knockout with multi-pathway kinase profiling, cytokine ELISA and TNFDeltaARE disease cross; later corroborated by T106M knock-in chemical genetics","pmids":["16287858","17855341"],"confidence":"High","gaps":["Compensation by p38alpha not formally excluded for all phenotypes","Did not address non-immune tissue-specific roles"]},{"year":2005,"claim":"Established isoform- and cell-type-specific in vivo functions for MAPK11 in nervous tissue and vascular biology, distinguishing it from p38alpha by selective knockdown.","evidence":"Isoform-specific antisense in spinal microglia with pain behavior assays; p38beta knockout/rescue for CO-induced caveolin-1; dominant-negative isoform comparisons","pmids":["15748168","16051704","11500933"],"confidence":"High","gaps":["Direct substrates in microglial pain signaling not identified","Mechanism of CO-induced p38beta activation unresolved"]},{"year":2008,"claim":"Explained the divergent subcellular signaling of the two isoforms by mapping the residues that exclude the p38beta-PRAK complex from the nucleus.","evidence":"Chimeric and point mutants (Gly145/Val156 vs Asp145/Leu156), subcellular fractionation, nuclear import assays and proliferation readouts","pmids":["18268017"],"confidence":"High","gaps":["Generalizability of cytosolic restriction to other p38beta partners not tested","Consequences for the full p38beta substrate set not mapped"]},{"year":2009,"claim":"Provided a structural basis for p38beta's distinct inhibitor and substrate behavior by solving its crystal structure and revealing a reduced ATP pocket.","evidence":"X-ray crystallography of p38beta versus p38alpha mutants at 2.05 Angstrom","pmids":["19622861"],"confidence":"High","gaps":["Structure of active/phosphorylated state and substrate complexes not determined","Link to autophosphorylation mechanism not yet structural"]},{"year":2011,"claim":"Defined developmental and signaling roles, showing p38beta partners with p38alpha for embryonic cardiovascular development and selectively activates mTORC1 via Raptor under arsenite stress.","evidence":"Double-knockout and p38beta knock-in mice for development; co-IP and in vitro phosphorylation of Raptor Ser863/Ser771 with stimulus-specificity controls","pmids":["21768366","21757713","21865449"],"confidence":"High","gaps":["Why arsenite uniquely couples p38beta to Raptor is unclear","Non-redundant developmental substrates of p38beta not identified"]},{"year":2012,"claim":"Identified the defining p38beta-specific catabolic mechanism in muscle: phosphorylation of C/EBPbeta at Thr-188 to drive atrogin1/MAFbx expression.","evidence":"Phosphopeptide mapping, ChIP, C/EBPbeta T188A mutagenesis, siRNA, and C/EBPbeta-null mice with in vivo muscle injection","pmids":["23046544"],"confidence":"High","gaps":["Upstream activator of p38beta in catabolic muscle not fully defined here","Did not yet integrate autophagy or acetylation arms"]},{"year":2013,"claim":"Expanded the p38beta substrate map to Ca2+ homeostasis and revealed a selective stabilizing partner, showing direct STIM1 phosphorylation and ILK-dependent control of p38beta levels.","evidence":"Isoform-specific siRNA with STIM1 phosphorylation and Ca2+ entry assays; reciprocal co-IP, BiFC/PLA and MG132 rescue for ILK-p38beta","pmids":["23625915","23435415"],"confidence":"High","gaps":["Phosphosites on STIM1 not individually mapped","Mechanism of ILK-mediated p38beta protein protection not detailed"]},{"year":2014,"claim":"Resolved the autoregulatory logic of MAPK11, identifying both an activating autophosphorylation element and inhibitory autophosphorylation sites that tune basal activity.","evidence":"In vitro autophosphorylation, domain-swap chimeras, mass spectrometry of T241/S261, mutagenesis and tissue phosphorylation analysis","pmids":["25006254","26976637"],"confidence":"High","gaps":["Upstream signals that toggle inhibitory autophosphorylation in vivo unknown","Structural basis of the autophosphorylation element not solved"]},{"year":2016,"claim":"Demonstrated mitochondrial and additional muscle-catabolic functions, placing p38beta inside mitochondria phosphorylating MnSOD and at the center of activin A-induced wasting.","evidence":"In vitro kinase and co-IP for MnSOD with T79A/S106A mutants and in vivo I/R models; muscle-specific p38beta knockout and isoform-specific siRNA for activin A catabolism","pmids":["27930699","27897407"],"confidence":"High","gaps":["Import mechanism delivering p38beta to mitochondria not defined","Activin A-to-p38beta activation steps incompletely mapped"]},{"year":2017,"claim":"Extended p38beta into neurological disease and neuromodulatory signaling, showing it modulates mutant huntingtin levels and drives microglial beta-endorphin via PKA-p38beta-CREB.","evidence":"MAPK11 knockout in HD knockin mice with kinase-dead controls and behavioral rescue; isoform-specific siRNA with cAMP, phospho-cascade, POMC ELISA and intrathecal behavioral assays","pmids":["29151587","28202578"],"confidence":"High","gaps":["Direct substrate linking p38beta to mHTT stability not identified","Whether CREB is a direct p38beta substrate in this cascade not shown"]},{"year":2020,"claim":"Completed the multi-arm model of cachexia by adding p300 Ser-12 phosphorylation and ULK1-dependent autophagy, and provided a druggable handle via preferential p38beta inhibition.","evidence":"Genetic knockdown, p300 phosphorylation and C/EBPbeta acetylation assays, muscle-specific knockout, ULK1 S555 phosphorylation and co-IP, nilotinib treatment with survival analysis","pmids":["33355181","31225455"],"confidence":"High","gaps":["Relative contribution of UPP versus autophagy arms not quantified","Off-target effects of nilotinib not fully excluded"]},{"year":2021,"claim":"Identified a stress-responsive substrate controlling membrane trafficking, showing p38 phosphorylation of SNX27 Ser51 reshapes cargo binding to inhibit endocytic recycling.","evidence":"Phosphoproteomics, in vitro kinase assay, SNX27 S51 mutagenesis, cargo-binding and recycling assays across multiple stressors","pmids":["33605979"],"confidence":"High","gaps":["Relative roles of p38alpha versus p38beta on SNX27 not separated","Physiological receptor cargoes most affected not enumerated"]},{"year":2023,"claim":"Implicated MAPK11 in viral and oncogenic contexts, defining it as a SARS-CoV-2 host dependency factor and a RUNX2-stabilizing partner in renal carcinoma.","evidence":"Genetic screening with multi-omics for SARS-CoV-2; co-IP and cycloheximide-chase RUNX2 stability assays with proliferation/migration readouts in ccRCC","pmids":["37345956","37525479"],"confidence":"Medium","gaps":["SARS-CoV-2 substrates remain putative without individual biochemical validation","Direct phosphorylation underlying RUNX2 stabilization not demonstrated"]},{"year":null,"claim":"How distinct upstream stimuli select among p38beta's many substrates and subcellular pools (nuclear-excluded cytosol, mitochondria, endosomes) to produce divergent pro-survival, catabolic, and trafficking outcomes remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unifying model linking stimulus identity to substrate selection","Mechanism targeting p38beta to mitochondria and other compartments undefined","Structural basis of substrate discrimination versus p38alpha not solved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[0,16,30,32,34,39,44,45]},{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,1,16,30,39,45]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,32]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[25,30,35]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[10,14]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[39]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,2,30,34]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[5,8,36,45]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[43]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,1,32,44]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[29,31]}],"complexes":[],"partners":["MAP2K6","RAPTOR","STIM1","ILK","PRAK","ULK1","SOD2","SNX27"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q15759","full_name":"Mitogen-activated protein kinase 11","aliases":["Mitogen-activated protein kinase p38 beta","MAP kinase p38 beta","p38b","Stress-activated protein kinase 2b","SAPK2b","p38-2"],"length_aa":364,"mass_kda":41.4,"function":"Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway (PubMed:12452429, PubMed:20626350, PubMed:35857590). MAPK11 is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as pro-inflammatory cytokines or physical stress leading to direct activation of transcription factors (PubMed:12452429, PubMed:20626350, PubMed:35857590). Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 to 300 substrates each (PubMed:12452429, PubMed:20626350, PubMed:35857590). MAPK11 functions are mostly redundant with those of MAPK14 (PubMed:12452429, PubMed:20626350, PubMed:35857590). Some of the targets are downstream kinases which are activated through phosphorylation and further phosphorylate additional targets (PubMed:12452429, PubMed:20626350). RPS6KA5/MSK1 and RPS6KA4/MSK2 can directly phosphorylate and activate transcription factors such as CREB1, ATF1, the NF-kappa-B isoform RELA/NFKB3, STAT1 and STAT3, but can also phosphorylate histone H3 and the nucleosomal protein HMGN1 (PubMed:9687510). RPS6KA5/MSK1 and RPS6KA4/MSK2 play important roles in the rapid induction of immediate-early genes in response to stress or mitogenic stimuli, either by inducing chromatin remodeling or by recruiting the transcription machinery. On the other hand, two other kinase targets, MAPKAPK2/MK2 and MAPKAPK3/MK3, participate in the control of gene expression mostly at the post-transcriptional level, by phosphorylating ZFP36 (tristetraprolin) and ELAVL1, and by regulating EEF2K, which is important for the elongation of mRNA during translation. MKNK1/MNK1 and MKNK2/MNK2, two other kinases activated by p38 MAPKs, regulate protein synthesis by phosphorylating the initiation factor EIF4E2 (PubMed:11154262). In the cytoplasm, the p38 MAPK pathway is an important regulator of protein turnover. For example, CFLAR is an inhibitor of TNF-induced apoptosis whose proteasome-mediated degradation is regulated by p38 MAPK phosphorylation. Ectodomain shedding of transmembrane proteins is regulated by p38 MAPKs as well. In response to inflammatory stimuli, p38 MAPKs phosphorylate the membrane-associated metalloprotease ADAM17. Such phosphorylation is required for ADAM17-mediated ectodomain shedding of TGF-alpha family ligands, which results in the activation of EGFR signaling and cell proliferation. Additional examples of p38 MAPK substrates are the FGFR1. FGFR1 can be translocated from the extracellular space into the cytosol and nucleus of target cells, and regulates processes such as rRNA synthesis and cell growth. FGFR1 translocation requires p38 MAPK activation. In the nucleus, many transcription factors are phosphorylated and activated by p38 MAPKs in response to different stimuli. Classical examples include ATF1, ATF2, ATF6, ELK1, PTPRH, DDIT3, TP53/p53 and MEF2C and MEF2A (PubMed:10330143, PubMed:15356147, PubMed:9430721). The p38 MAPKs are emerging as important modulators of gene expression by regulating chromatin modifiers and remodelers (PubMed:10330143, PubMed:15356147, PubMed:9430721). The promoters of several genes involved in the inflammatory response, such as IL6, IL8 and IL12B, display a p38 MAPK-dependent enrichment of histone H3 phosphorylation on 'Ser-10' (H3S10ph) in LPS-stimulated myeloid cells. This phosphorylation enhances the accessibility of the cryptic NF-kappa-B-binding sites marking promoters for increased NF-kappa-B recruitment. Phosphorylates NLRP1 downstream of MAP3K20/ZAK in response to UV-B irradiation and ribosome collisions, promoting activation of the NLRP1 inflammasome and pyroptosis (PubMed:35857590). Phosphorylates methyltransferase DOT1L on 'Ser-834', 'Thr-900', 'Ser-902', 'Thr-984', 'Ser-1001', 'Ser-1009' and 'Ser-1104' (PubMed:38270553)","subcellular_location":"Cytoplasm; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q15759/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MAPK11","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"MAPKAPK2","stoichiometry":0.2},{"gene":"MAPKAPK3","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/MAPK11","total_profiled":1310},"omim":[{"mim_id":"607175","title":"DUAL-SPECIFICITY PHOSPHATASE 16; DUSP16","url":"https://www.omim.org/entry/607175"},{"mim_id":"606723","title":"MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 5; MAPKAPK5","url":"https://www.omim.org/entry/606723"},{"mim_id":"604293","title":"PLEXIN B2; PLXNB2","url":"https://www.omim.org/entry/604293"},{"mim_id":"602898","title":"MITOGEN-ACTIVATED PROTEIN KINASE 11; MAPK11","url":"https://www.omim.org/entry/602898"},{"mim_id":"303600","title":"COFFIN-LOWRY SYNDROME; CLS","url":"https://www.omim.org/entry/303600"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"brain","ntpm":62.6}],"url":"https://www.proteinatlas.org/search/MAPK11"},"hgnc":{"alias_symbol":["p38-2","p38Beta","SAPK2"],"prev_symbol":["PRKM11"]},"alphafold":{"accession":"Q15759","domains":[{"cath_id":"3.30.200.20","chopping":"19-108_322-346","consensus_level":"high","plddt":93.1855,"start":19,"end":346},{"cath_id":"1.10.510.10","chopping":"110-315","consensus_level":"high","plddt":89.6934,"start":110,"end":315}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q15759","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q15759-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q15759-F1-predicted_aligned_error_v6.png","plddt_mean":89.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MAPK11","jax_strain_url":"https://www.jax.org/strain/search?query=MAPK11"},"sequence":{"accession":"Q15759","fasta_url":"https://rest.uniprot.org/uniprotkb/Q15759.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q15759/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q15759"}},"corpus_meta":[{"pmid":"9687510","id":"PMC_9687510","title":"Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB.","date":"1998","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9687510","citation_count":845,"is_preprint":false},{"pmid":"8663524","id":"PMC_8663524","title":"Characterization of the structure and function of a new mitogen-activated protein kinase (p38beta).","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8663524","citation_count":642,"is_preprint":false},{"pmid":"9029150","id":"PMC_9029150","title":"Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38).","date":"1997","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9029150","citation_count":327,"is_preprint":false},{"pmid":"9832563","id":"PMC_9832563","title":"SAPK2/p38-dependent F-actin reorganization regulates early membrane blebbing during stress-induced apoptosis.","date":"1998","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/9832563","citation_count":262,"is_preprint":false},{"pmid":"10744763","id":"PMC_10744763","title":"Vascular endothelial growth factor (VEGF)-driven actin-based motility is mediated by VEGFR2 and requires concerted activation of stress-activated protein kinase 2 (SAPK2/p38) and geldanamycin-sensitive phosphorylation of focal adhesion kinase.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10744763","citation_count":258,"is_preprint":false},{"pmid":"9632706","id":"PMC_9632706","title":"Induction of apoptosis by SB202190 through inhibition of p38beta mitogen-activated protein kinase.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9632706","citation_count":244,"is_preprint":false},{"pmid":"16287858","id":"PMC_16287858","title":"Generation and characterization of p38beta (MAPK11) gene-targeted mice.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16287858","citation_count":197,"is_preprint":false},{"pmid":"14724572","id":"PMC_14724572","title":"Phosphorylation of tyrosine 1214 on VEGFR2 is required for VEGF-induced activation of Cdc42 upstream of SAPK2/p38.","date":"2004","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/14724572","citation_count":174,"is_preprint":false},{"pmid":"10593919","id":"PMC_10593919","title":"Regulation of glucose transport and glycogen synthesis in L6 muscle cells during oxidative stress. Evidence for cross-talk between the insulin and SAPK2/p38 mitogen-activated protein kinase signaling pathways.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10593919","citation_count":152,"is_preprint":false},{"pmid":"9235954","id":"PMC_9235954","title":"p38-2, a novel mitogen-activated protein kinase with distinct properties.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9235954","citation_count":148,"is_preprint":false},{"pmid":"16966330","id":"PMC_16966330","title":"Phosphorylation of Tyr1214 within VEGFR-2 triggers the recruitment of Nck and activation of Fyn leading to SAPK2/p38 activation and endothelial cell migration in response to VEGF.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16966330","citation_count":134,"is_preprint":false},{"pmid":"15748168","id":"PMC_15748168","title":"Spinal p38beta isoform mediates tissue injury-induced hyperalgesia and spinal sensitization.","date":"2005","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15748168","citation_count":118,"is_preprint":false},{"pmid":"31822654","id":"PMC_31822654","title":"Circ_0001955 facilitates hepatocellular carcinoma (HCC) tumorigenesis by sponging miR-516a-5p to release TRAF6 and MAPK11.","date":"2019","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/31822654","citation_count":107,"is_preprint":false},{"pmid":"16051704","id":"PMC_16051704","title":"Caveolin-1 expression by means of p38beta mitogen-activated protein kinase mediates the antiproliferative effect of carbon monoxide.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16051704","citation_count":100,"is_preprint":false},{"pmid":"12820653","id":"PMC_12820653","title":"Integrin alphavbeta3, requirement for VEGFR2-mediated activation of SAPK2/p38 and for Hsp90-dependent phosphorylation of focal adhesion kinase in endothelial cells activated by VEGF.","date":"2003","source":"Cell stress & chaperones","url":"https://pubmed.ncbi.nlm.nih.gov/12820653","citation_count":98,"is_preprint":false},{"pmid":"11448946","id":"PMC_11448946","title":"Transendothelial migration of colon carcinoma cells requires expression of E-selectin by endothelial cells and activation of stress-activated protein kinase-2 (SAPK2/p38) in the tumor cells.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11448946","citation_count":97,"is_preprint":false},{"pmid":"10207622","id":"PMC_10207622","title":"Regulation of actin dynamics by stress-activated protein kinase 2 (SAPK2)-dependent phosphorylation of heat-shock protein of 27 kDa (Hsp27).","date":"1999","source":"Biochemical Society symposium","url":"https://pubmed.ncbi.nlm.nih.gov/10207622","citation_count":89,"is_preprint":false},{"pmid":"24905917","id":"PMC_24905917","title":"Activation of the MAPK11/12/13/14 (p38 MAPK) pathway regulates the transcription of autophagy genes in response to oxidative stress induced by a novel copper complex in HeLa cells.","date":"2014","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/24905917","citation_count":88,"is_preprint":false},{"pmid":"27897407","id":"PMC_27897407","title":"Activin A induces skeletal muscle catabolism via p38β mitogen-activated protein kinase.","date":"2016","source":"Journal of cachexia, sarcopenia and muscle","url":"https://pubmed.ncbi.nlm.nih.gov/27897407","citation_count":78,"is_preprint":false},{"pmid":"11162833","id":"PMC_11162833","title":"The Epstein-Barr virus latent membrane protein 1 induces interleukin-10 in Burkitt's lymphoma cells but not in Hodgkin's cells involving the p38/SAPK2 pathway.","date":"2001","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/11162833","citation_count":77,"is_preprint":false},{"pmid":"20724307","id":"PMC_20724307","title":"Oestrogen prevents cardiomyocyte apoptosis by suppressing p38α-mediated activation of p53 and by down-regulating p53 inhibition on p38β.","date":"2010","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/20724307","citation_count":76,"is_preprint":false},{"pmid":"11003596","id":"PMC_11003596","title":"Cyclic stretch activates p38 SAPK2-, ErbB2-, and AT1-dependent signaling in bladder smooth muscle cells.","date":"2000","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11003596","citation_count":70,"is_preprint":false},{"pmid":"17855341","id":"PMC_17855341","title":"Chemical genetics define the roles of p38alpha and p38beta in acute and chronic inflammation.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17855341","citation_count":69,"is_preprint":false},{"pmid":"29128611","id":"PMC_29128611","title":"Intrathecal administration of antisense oligonucleotide against p38α but not p38β MAP kinase isoform reduces neuropathic and postoperative pain and TLR4-induced pain in male mice.","date":"2017","source":"Brain, behavior, and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/29128611","citation_count":63,"is_preprint":false},{"pmid":"32634680","id":"PMC_32634680","title":"Optimal linker length for small molecule PROTACs that selectively target p38α and p38β for degradation.","date":"2020","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32634680","citation_count":62,"is_preprint":false},{"pmid":"22522454","id":"PMC_22522454","title":"TGF-β1 induces endothelial cell apoptosis by shifting VEGF activation of p38(MAPK) from the prosurvival p38β to proapoptotic p38α.","date":"2012","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/22522454","citation_count":62,"is_preprint":false},{"pmid":"10820433","id":"PMC_10820433","title":"Constitutive activity and differential localization of p38alpha and p38beta MAPKs in adult mouse brain.","date":"2000","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/10820433","citation_count":61,"is_preprint":false},{"pmid":"17053028","id":"PMC_17053028","title":"Diazoxide prevents diabetes through inhibiting pancreatic beta-cells from apoptosis via Bcl-2/Bax rate and p38-beta mitogen-activated protein kinase.","date":"2006","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/17053028","citation_count":60,"is_preprint":false},{"pmid":"30236054","id":"PMC_30236054","title":"The sucrose non-fermenting-1-related protein kinases SAPK1 and SAPK2 function collaboratively as positive regulators of salt stress tolerance in rice.","date":"2018","source":"BMC plant biology","url":"https://pubmed.ncbi.nlm.nih.gov/30236054","citation_count":59,"is_preprint":false},{"pmid":"16120828","id":"PMC_16120828","title":"Epidermal growth factor stimulation of trophoblast differentiation requires MAPK11/14 (p38 MAP kinase) activation.","date":"2005","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/16120828","citation_count":57,"is_preprint":false},{"pmid":"18192325","id":"PMC_18192325","title":"Transforming growth factor-beta-induced alpha-smooth muscle cell actin expression in renal proximal tubular cells is regulated by p38beta mitogen-activated protein kinase, extracellular signal-regulated protein kinase1,2 and the Smad signalling during epithelial-myofibroblast transdifferentiation.","date":"2008","source":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association","url":"https://pubmed.ncbi.nlm.nih.gov/18192325","citation_count":57,"is_preprint":false},{"pmid":"23046544","id":"PMC_23046544","title":"p38β MAPK upregulates atrogin1/MAFbx by specific phosphorylation of C/EBPβ.","date":"2012","source":"Skeletal muscle","url":"https://pubmed.ncbi.nlm.nih.gov/23046544","citation_count":53,"is_preprint":false},{"pmid":"21757713","id":"PMC_21757713","title":"Phosphorylation of Raptor by p38beta participates in arsenite-induced mammalian target of rapamycin complex 1 (mTORC1) activation.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21757713","citation_count":53,"is_preprint":false},{"pmid":"10362531","id":"PMC_10362531","title":"Activation of the neutrophil NADPH oxidase is inhibited by SB 203580, a specific inhibitor of SAPK2/p38.","date":"1999","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10362531","citation_count":53,"is_preprint":false},{"pmid":"21768366","id":"PMC_21768366","title":"Genetic analysis of specific and redundant roles for p38alpha and p38beta MAPKs during mouse development.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21768366","citation_count":52,"is_preprint":false},{"pmid":"29249556","id":"PMC_29249556","title":"Both classic Gs-cAMP/PKA/CREB and alternative Gs-cAMP/PKA/p38β/CREB signal pathways mediate exenatide-stimulated expression of M2 microglial markers.","date":"2017","source":"Journal of neuroimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/29249556","citation_count":48,"is_preprint":false},{"pmid":"23711149","id":"PMC_23711149","title":"Thymoquinone induces apoptosis in oral cancer cells through p38β inhibition.","date":"2013","source":"The American journal of Chinese medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23711149","citation_count":48,"is_preprint":false},{"pmid":"23625915","id":"PMC_23625915","title":"Store-operated Ca2+ entry (SOCE) induced by protease-activated receptor-1 mediates STIM1 protein phosphorylation to inhibit SOCE in endothelial cells through AMP-activated protein kinase and p38β mitogen-activated protein kinase.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23625915","citation_count":43,"is_preprint":false},{"pmid":"14680475","id":"PMC_14680475","title":"Identification of glycogen synthase as a new substrate for stress-activated protein kinase 2b/p38beta.","date":"2004","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/14680475","citation_count":43,"is_preprint":false},{"pmid":"28189715","id":"PMC_28189715","title":"Cynandione A attenuates neuropathic pain through p38β MAPK-mediated spinal microglial expression of β-endorphin.","date":"2017","source":"Brain, behavior, and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/28189715","citation_count":42,"is_preprint":false},{"pmid":"15048855","id":"PMC_15048855","title":"p38/SAPK2 controls gap junction closure in astrocytes.","date":"2004","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/15048855","citation_count":41,"is_preprint":false},{"pmid":"18641461","id":"PMC_18641461","title":"Efficient adult skeletal muscle regeneration in mice deficient in p38beta, p38gamma and p38delta MAP kinases.","date":"2008","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/18641461","citation_count":39,"is_preprint":false},{"pmid":"15572410","id":"PMC_15572410","title":"p38alpha, but not p38beta, inhibits the phosphorylation and presence of c-FLIPS in DISC to potentiate Fas-mediated caspase-8 activation and type I apoptotic signaling.","date":"2004","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/15572410","citation_count":38,"is_preprint":false},{"pmid":"9412491","id":"PMC_9412491","title":"The mitogen-activated protein kinase p38-2 is necessary for the inhibition of N-type calcium current by bradykinin.","date":"1998","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/9412491","citation_count":37,"is_preprint":false},{"pmid":"31225455","id":"PMC_31225455","title":"p38β MAPK mediates ULK1-dependent induction of autophagy in skeletal muscle of tumor-bearing mice.","date":"2018","source":"Cell stress","url":"https://pubmed.ncbi.nlm.nih.gov/31225455","citation_count":37,"is_preprint":false},{"pmid":"29151587","id":"PMC_29151587","title":"Suppression of MAPK11 or HIPK3 reduces mutant Huntingtin levels in Huntington's disease models.","date":"2017","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/29151587","citation_count":36,"is_preprint":false},{"pmid":"33605979","id":"PMC_33605979","title":"Phosphorylation of SNX27 by MAPK11/14 links cellular stress-signaling pathways with endocytic recycling.","date":"2021","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/33605979","citation_count":36,"is_preprint":false},{"pmid":"25012593","id":"PMC_25012593","title":"Inhibition of neuronal p38α, but not p38β MAPK, provides neuroprotection against three different neurotoxic insults.","date":"2014","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/25012593","citation_count":36,"is_preprint":false},{"pmid":"25006254","id":"PMC_25006254","title":"The p38β mitogen-activated protein kinase possesses an intrinsic autophosphorylation activity, generated by a short region composed of the α-G helix and MAPK insert.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25006254","citation_count":35,"is_preprint":false},{"pmid":"28202578","id":"PMC_28202578","title":"p38β Mitogen-Activated Protein Kinase Signaling Mediates Exenatide-Stimulated Microglial β-Endorphin Expression.","date":"2017","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28202578","citation_count":34,"is_preprint":false},{"pmid":"26363230","id":"PMC_26363230","title":"Gene structure, molecular characterization and transcriptional expression of two p38 isoforms (MAPK11 and MAPK14) from rock bream (Oplegnathus fasciatus).","date":"2015","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26363230","citation_count":34,"is_preprint":false},{"pmid":"14997018","id":"PMC_14997018","title":"Nerve growth factor pretreatment attenuates oxygen and glucose deprivation-induced c-Jun amino-terminal kinase 1 and stress-activated kinases p38alpha and p38beta activation and confers neuroprotection in the pheochromocytoma PC12 Model.","date":"2004","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/14997018","citation_count":34,"is_preprint":false},{"pmid":"19622861","id":"PMC_19622861","title":"The three-dimensional structure of MAP kinase p38beta: different features of the ATP-binding site in p38beta compared with p38alpha.","date":"2009","source":"Acta crystallographica. Section D, Biological crystallography","url":"https://pubmed.ncbi.nlm.nih.gov/19622861","citation_count":33,"is_preprint":false},{"pmid":"16179830","id":"PMC_16179830","title":"JNK/SAPK and p38 SAPK-2 mediate mechanical stretch-induced apoptosis via caspase-3 and -9 in NRK-52E renal epithelial cells.","date":"2005","source":"Nephron. Experimental nephrology","url":"https://pubmed.ncbi.nlm.nih.gov/16179830","citation_count":32,"is_preprint":false},{"pmid":"27930699","id":"PMC_27930699","title":"Estrogen Protects the Female Heart from Ischemia/Reperfusion Injury through Manganese Superoxide Dismutase Phosphorylation by Mitochondrial p38β at Threonine 79 and Serine 106.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27930699","citation_count":32,"is_preprint":false},{"pmid":"33448300","id":"PMC_33448300","title":"MAPK11 regulates seed germination and ABA signaling in tomato by phosphorylating SnRKs.","date":"2021","source":"Journal of experimental botany","url":"https://pubmed.ncbi.nlm.nih.gov/33448300","citation_count":30,"is_preprint":false},{"pmid":"11500933","id":"PMC_11500933","title":"p38beta MAP kinase protects rat mesangial cells from TNF-alpha-induced apoptosis.","date":"2001","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11500933","citation_count":30,"is_preprint":false},{"pmid":"33355181","id":"PMC_33355181","title":"Cancer-Induced Muscle Wasting Requires p38β MAPK Activation of p300.","date":"2020","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/33355181","citation_count":29,"is_preprint":false},{"pmid":"16116476","id":"PMC_16116476","title":"E2F1 stability is regulated by a novel-PKC/p38beta MAP kinase signaling pathway during keratinocyte differentiation.","date":"2006","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/16116476","citation_count":29,"is_preprint":false},{"pmid":"14737674","id":"PMC_14737674","title":"Synthetic anisomycin analogues activating the JNK/SAPK1 and p38/SAPK2 pathways.","date":"2003","source":"Organic & biomolecular chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14737674","citation_count":29,"is_preprint":false},{"pmid":"18268017","id":"PMC_18268017","title":"Determinants that control the distinct subcellular localization of p38alpha-PRAK and p38beta-PRAK complexes.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18268017","citation_count":29,"is_preprint":false},{"pmid":"23435415","id":"PMC_23435415","title":"Selective regulation of p38β protein and signaling by integrin-linked kinase mediates bladder cancer cell migration.","date":"2013","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/23435415","citation_count":28,"is_preprint":false},{"pmid":"26061537","id":"PMC_26061537","title":"The problem of pyridinyl imidazole class inhibitors of MAPK14/p38α and MAPK11/p38β in autophagy research.","date":"2015","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/26061537","citation_count":26,"is_preprint":false},{"pmid":"25066918","id":"PMC_25066918","title":"MAPK11 in breast cancer cells enhances osteoclastogenesis and bone resorption.","date":"2014","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/25066918","citation_count":26,"is_preprint":false},{"pmid":"32922543","id":"PMC_32922543","title":"TRIM67 inhibits tumor proliferation and metastasis by mediating MAPK11 in Colorectal Cancer.","date":"2020","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32922543","citation_count":26,"is_preprint":false},{"pmid":"24465521","id":"PMC_24465521","title":"Mitochondrial p38β and manganese superoxide dismutase interaction mediated by estrogen in cardiomyocytes.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24465521","citation_count":25,"is_preprint":false},{"pmid":"10879630","id":"PMC_10879630","title":"The mitogen-activated protein kinase p38 pathway is conserved in metazoans: cloning and activation of p38 of the SAPK2 subfamily from the sponge Suberites domuncula.","date":"2000","source":"Biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/10879630","citation_count":25,"is_preprint":false},{"pmid":"21865449","id":"PMC_21865449","title":"p38α and p38β mitogen-activated protein kinases determine cholinergic transdifferentiation of sympathetic neurons.","date":"2011","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/21865449","citation_count":23,"is_preprint":false},{"pmid":"19082897","id":"PMC_19082897","title":"Isoflavone genistein protects human vascular endothelial cells against tumor necrosis factor-alpha-induced apoptosis through the p38beta mitogen-activated protein kinase.","date":"2009","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/19082897","citation_count":23,"is_preprint":false},{"pmid":"33053909","id":"PMC_33053909","title":"p38β and Cancer: The Beginning of the Road.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33053909","citation_count":22,"is_preprint":false},{"pmid":"34174910","id":"PMC_34174910","title":"p38β - MAPK11 and its role in female cancers.","date":"2021","source":"Journal of ovarian research","url":"https://pubmed.ncbi.nlm.nih.gov/34174910","citation_count":21,"is_preprint":false},{"pmid":"37345956","id":"PMC_37345956","title":"SARS-CoV-2 hijacks p38β/MAPK11 to promote virus replication.","date":"2023","source":"mBio","url":"https://pubmed.ncbi.nlm.nih.gov/37345956","citation_count":21,"is_preprint":false},{"pmid":"31811717","id":"PMC_31811717","title":"MYB57 transcriptionally regulates MAPK11 to interact with PAL2;3 and modulate rice allelopathy.","date":"2020","source":"Journal of experimental botany","url":"https://pubmed.ncbi.nlm.nih.gov/31811717","citation_count":21,"is_preprint":false},{"pmid":"35734958","id":"PMC_35734958","title":"miR-143-Mediated Responses to Betaine Supplement Repress Lipogenesis and Hepatic Gluconeogenesis by Targeting MAT1a and MAPK11.","date":"2022","source":"Journal of agricultural and food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/35734958","citation_count":20,"is_preprint":false},{"pmid":"21911485","id":"PMC_21911485","title":"Inhibition of SAPK2/p38 enhances sensitivity to mTORC1 inhibition by blocking IRES-mediated translation initiation in glioblastoma.","date":"2011","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/21911485","citation_count":20,"is_preprint":false},{"pmid":"29747487","id":"PMC_29747487","title":"Diagnostic Significance of p38 Isoforms (p38α, p38β, p38γ, p38δ) in Head and Neck Squamous Cell Carcinoma: Comparative Serum Level Evaluation and Design of Novel Peptide Inhibitor Targeting the Same.","date":"2018","source":"Cancer research and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/29747487","citation_count":20,"is_preprint":false},{"pmid":"21777656","id":"PMC_21777656","title":"p38β MAPK affords cytoprotection against oxidative stress-induced astrocyte apoptosis via induction of αB-crystallin and its anti-apoptotic function.","date":"2011","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/21777656","citation_count":20,"is_preprint":false},{"pmid":"31123170","id":"PMC_31123170","title":"Knocking down of LINC01220 inhibits proliferation and induces apoptosis of endometrial carcinoma through silencing MAPK11.","date":"2019","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/31123170","citation_count":18,"is_preprint":false},{"pmid":"32514747","id":"PMC_32514747","title":"SAPK2 contributes to rice yield by modulating nitrogen metabolic processes under reproductive stage drought stress.","date":"2020","source":"Rice (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/32514747","citation_count":18,"is_preprint":false},{"pmid":"23457629","id":"PMC_23457629","title":"Deficiency in p38β MAPK fails to inhibit cytokine production or protect neurons against inflammatory insult in in vitro and in vivo mouse models.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23457629","citation_count":17,"is_preprint":false},{"pmid":"21925493","id":"PMC_21925493","title":"p38β-regulated induction of the heat shock response by carbon monoxide releasing molecule CORM-2 mediates cytoprotection in lung cells in vitro.","date":"2011","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/21925493","citation_count":17,"is_preprint":false},{"pmid":"29415197","id":"PMC_29415197","title":"lncRNA ENSMUST00000134285 Increases MAPK11 Activity, Regulating Aging-Related Myocardial Apoptosis.","date":"2018","source":"The journals of gerontology. Series A, Biological sciences and medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29415197","citation_count":15,"is_preprint":false},{"pmid":"10608813","id":"PMC_10608813","title":"A short lived protein involved in the heat shock sensing mechanism responsible for stress-activated protein kinase 2 (SAPK2/p38) activation.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10608813","citation_count":15,"is_preprint":false},{"pmid":"26976637","id":"PMC_26976637","title":"p38β Mitogen-Activated Protein Kinase Modulates Its Own Basal Activity by Autophosphorylation of the Activating Residue Thr180 and the Inhibitory Residues Thr241 and Ser261.","date":"2016","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/26976637","citation_count":15,"is_preprint":false},{"pmid":"26666822","id":"PMC_26666822","title":"Clinicopathological significance of p38β, p38γ, and p38δ and its biological roles in esophageal squamous cell carcinoma.","date":"2015","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26666822","citation_count":13,"is_preprint":false},{"pmid":"22515544","id":"PMC_22515544","title":"p38β MAP kinase as a therapeutic target for pancreatic cancer.","date":"2012","source":"Chemical biology & drug design","url":"https://pubmed.ncbi.nlm.nih.gov/22515544","citation_count":12,"is_preprint":false},{"pmid":"18515110","id":"PMC_18515110","title":"COX-2 promoter activation by AT1R-Gq-PAK-p38beta signaling in intestinal epithelial cells.","date":"2008","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/18515110","citation_count":12,"is_preprint":false},{"pmid":"25936522","id":"PMC_25936522","title":"Coronin 1A depletion protects endothelial cells from TNFα-induced apoptosis by modulating p38β expression and activation.","date":"2015","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/25936522","citation_count":12,"is_preprint":false},{"pmid":"31661126","id":"PMC_31661126","title":"Roles of p38α and p38β mitogen‑activated protein kinase isoforms in human malignant melanoma A375 cells.","date":"2019","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31661126","citation_count":11,"is_preprint":false},{"pmid":"12763629","id":"PMC_12763629","title":"Dynamic expression of p38beta MAPK in neurons and astrocytes after transient focal ischemia.","date":"2003","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/12763629","citation_count":11,"is_preprint":false},{"pmid":"20053787","id":"PMC_20053787","title":"Interferon-alpha induces the growth inhibition of human T-cell leukaemia line Jurkat through p38alpha and p38beta.","date":"2010","source":"Journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20053787","citation_count":11,"is_preprint":false},{"pmid":"23639288","id":"PMC_23639288","title":"p27 suppresses cyclooxygenase-2 expression by inhibiting p38β and p38δ-mediated CREB phosphorylation upon arsenite exposure.","date":"2013","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/23639288","citation_count":10,"is_preprint":false},{"pmid":"20162623","id":"PMC_20162623","title":"Activin A induction of erythroid differentiation through MKK6-p38alpha/p38beta pathway is inhibited by follistatin.","date":"2010","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20162623","citation_count":10,"is_preprint":false},{"pmid":"25148579","id":"PMC_25148579","title":"Identification of p38β as a therapeutic target for the treatment of Sézary syndrome.","date":"2014","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/25148579","citation_count":10,"is_preprint":false},{"pmid":"37525479","id":"PMC_37525479","title":"Phosphorylated MAPK11 promotes the progression of clear cell renal cell carcinoma by maintaining RUNX2 protein abundance.","date":"2023","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37525479","citation_count":9,"is_preprint":false},{"pmid":"23807508","id":"PMC_23807508","title":"p38β, A novel regulatory target of Pokemon in hepatic cells.","date":"2013","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/23807508","citation_count":9,"is_preprint":false},{"pmid":"33310004","id":"PMC_33310004","title":"p38β (MAPK11) mediates gemcitabine-associated radiosensitivity in sarcoma experimental models.","date":"2020","source":"Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33310004","citation_count":8,"is_preprint":false},{"pmid":"37624097","id":"PMC_37624097","title":"Anthracycline cardiotoxicity is exacerbated by global p38β genetic ablation in a sexually dimorphic manner but unaltered by cardiomyocyte-specific p38α loss.","date":"2023","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/37624097","citation_count":6,"is_preprint":false},{"pmid":"34950660","id":"PMC_34950660","title":"Weight Loss in Cancer Patients Correlates With p38β MAPK Activation in Skeletal Muscle.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/34950660","citation_count":6,"is_preprint":false},{"pmid":"34814904","id":"PMC_34814904","title":"The role of MAPK11/12/13/14 (p38 MAPK) protein in dopamine agonist-resistant prolactinomas.","date":"2021","source":"BMC endocrine disorders","url":"https://pubmed.ncbi.nlm.nih.gov/34814904","citation_count":5,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":53876,"output_tokens":11976,"usd":0.170634,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":23280,"output_tokens":6605,"usd":0.140763,"stage2_stop_reason":"end_turn"},"total_usd":0.311397,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"MAPK11 (p38beta) is a MAP kinase containing a TGY dual phosphorylation site required for kinase activity; it is preferentially activated by MKK6 (rather than MKK3/MKK4), and shows strong substrate preference for ATF2 (~20-fold greater transactivation than p38alpha), with kinetic studies showing ~180-fold greater activity than p38 on ATF2.\",\n      \"method\": \"In vitro kinase assays, in vivo transfection, two-dimensional phosphopeptide analysis, reporter gene assays, site-directed mutagenesis of TGY motif\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinase assays with mutagenesis, multiple substrate analyses, replicated by independent characterization paper\",\n      \"pmids\": [\"8663524\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"MAPK11 (p38-2/p38beta) is activated by stress signals and proinflammatory cytokines; MEK6 is its preferred upstream kinase; it phosphorylates ATF2 and Sap-1a but not Elk1 with increased transcriptional activity; steady-state kinetics suggest a sequential kinetic mechanism.\",\n      \"method\": \"In vitro kinase assays, steady-state kinetic analysis, two-dimensional phosphopeptide analysis, reporter gene assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal methods (kinetics, phosphopeptide mapping, reporter assays), corroborated by [8663524]\",\n      \"pmids\": [\"9235954\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"MAPK11/SAPK2/p38 directly activates MSK1 in vitro; stress-induced activation of MSK1 in cells is blocked by SB203580 (a SAPK2/p38 inhibitor); MSK1 phosphorylates CREB at Ser133, suggesting SAPK2/p38 mediates stress-induced CREB activation via MSK1.\",\n      \"method\": \"In vitro kinase assay, pharmacological inhibition (SB203580), cell-based kinase activation assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro reconstitution plus pharmacological validation in multiple cell lines\",\n      \"pmids\": [\"9687510\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"MAPK11 (p38-2) is required for bradykinin-induced slow inhibition of N-type calcium current in NG108-15 cells; BK selectively activates p38-2, and SB203580 suppresses this inhibition, placing p38-2 downstream of G13 and Rac1/Cdc42 in this pathway.\",\n      \"method\": \"Electrophysiology, pharmacological inhibition (SB203580), kinase activity assays\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional epistasis with pharmacological inhibitor and isoform-selective activation data, single lab\",\n      \"pmids\": [\"9412491\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Expression of p38beta attenuates SB202190-induced apoptosis and cell death induced by Fas ligation and UV irradiation, whereas p38alpha expression mildly induces cell death; SB202190 induces apoptosis through CPP32-like caspases, and this is blocked by p38beta overexpression, indicating p38beta and p38alpha have opposing roles in apoptosis.\",\n      \"method\": \"Overexpression of p38 isoforms, caspase activity assays, nuclear condensation and DNA fragmentation assays, Bcl-2 overexpression rescue\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic overexpression with functional readout, multiple apoptosis assays, single lab\",\n      \"pmids\": [\"9632706\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"SAPK2/p38 (including MAPK11) mediates oxidative stress-induced actin cytoskeletal reorganization into stress fibers and focal adhesion formation in endothelial cells via phosphorylation of HSP27 through MAPKAP kinase-2/3; SAPK2 inhibition by SB203580 blocks membrane blebbing during H2O2-induced apoptosis; expression of non-phosphorylatable HSP27 prevents F-actin accumulation and blebbing.\",\n      \"method\": \"Pharmacological inhibition (SB203580, PD098059), expression of mutant HSP27, F-actin staining, caspase assay, DNA fragmentation\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple cell lines, genetic (mutant HSP27) and pharmacological approaches, multiple mechanistic readouts\",\n      \"pmids\": [\"9832563\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"SAPK2/p38 pathway activation mediates oxidant-induced inhibition of insulin-stimulated glucose transport in skeletal muscle cells; inhibiting p38 with SB202190 or SB203580 restores insulin-stimulated glucose transport but not glycogen synthesis, establishing p38 as a cross-talk node between stress and insulin signaling.\",\n      \"method\": \"Glucose transport assay, glycogen synthesis assay, in vitro kinase assays, pharmacological inhibition (SB202190, SB203580, wortmannin, PD98059)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional assays with selective inhibitors, multiple concentrations, single lab\",\n      \"pmids\": [\"10593919\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"SAPK2/p38 controls actin dynamics by phosphorylating HSP27 via MAPKAP kinase-2/3; this pathway mediates VEGF-induced actin reorganization and cell migration in vascular endothelial cells.\",\n      \"method\": \"Pharmacological inhibition, phosphorylation assays, cell migration assays\",\n      \"journal\": \"Biochemical Society symposium\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — supported by multiple linked studies; this is a review-type summary but consolidates experimental findings from primary work\",\n      \"pmids\": [\"10207622\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"A short-lived protein upstream of SAPK2/p38 constitutes a heat-shock-specific sensing mechanism; cycloheximide progressively desensitizes cells to heat-shock-induced SAPK2/p38 activation, and MG132 (proteasome inhibitor) constitutively activates SAPK2/p38, suggesting proteasomal degradation controls this upstream activator.\",\n      \"method\": \"Pharmacological treatments (cycloheximide, MG132, SB203580), kinase activity assays, heat shock desensitization experiments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple pharmacological tools, single lab, mechanistic pathway placement\",\n      \"pmids\": [\"10608813\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"VEGFR2-mediated SAPK2/p38 activation drives actin polymerization and cell migration in endothelial cells; VEGFR2 (not VEGFR1) is specifically responsible for SAPK2/p38 activation; the pathway is independent of FAK phosphorylation, which instead depends on HSP90.\",\n      \"method\": \"VEGFR1/VEGFR2-selective cell lines, neutralizing antibody, pharmacological inhibition (SB203580, geldanamycin), HSP90 overexpression rescue, migration assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — receptor-selective cell lines, genetic rescue, multiple pathway inhibitors, replicated across labs\",\n      \"pmids\": [\"10744763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"p38alpha and p38beta are constitutively active in adult mouse brain; p38alpha localizes to dendrites and cytoplasmic/nuclear regions of neurons, whereas p38beta is preferentially localized to the nucleus of neurons.\",\n      \"method\": \"Biochemical fractionation, immunohistochemistry, in vivo kinase activity assays\",\n      \"journal\": \"Journal of neuroscience research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization by immunohistochemistry with biochemical fractionation, single lab\",\n      \"pmids\": [\"10820433\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Cyclic mechanical stretch of bladder smooth muscle cells activates p38 SAPK2 and JNK/SAPK pathways independently of ERK-MAPK; p38 SAPK2 pathway contributes to stretch-stimulated DNA synthesis and HB-EGF gene expression, independently of ErbB2 and AT1 receptor pathways.\",\n      \"method\": \"Pharmacological inhibition (SB203580, PD98059), kinase activity assays, DNA synthesis measurement, gene expression analysis\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple inhibitors, independent pathway validation, single lab\",\n      \"pmids\": [\"11003596\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Tumor cell adhesion to E-selectin-expressing endothelium activates SAPK2/p38 in HT-29 tumor cells, leading to HSP27 phosphorylation and transendothelial migration; blocking SAPK2/p38 with SB203580 or dominant-negative SAPK2/p38 inhibits transendothelial migration but not cell adhesion.\",\n      \"method\": \"Dominant-negative MAPK11 expression, pharmacological inhibition (SB203580), phospho-HSP27 western blot, transendothelial migration assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic (dominant-negative) and pharmacological approaches with functional readout, multiple cell lines\",\n      \"pmids\": [\"11448946\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"p38beta (but not p38alpha) protects rat mesangial cells from TNF-alpha-induced apoptosis; p38beta does not affect TNF-alpha-induced NF-kappaB nuclear translocation.\",\n      \"method\": \"Adenovirus-mediated gene transfer of p38beta/dominant-negative p38beta, cell viability assay, NF-kappaB translocation assay, pharmacological inhibition (SB203580)\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — isoform-specific genetic overexpression and dominant-negative, single lab\",\n      \"pmids\": [\"11500933\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"SAPK2/p38 mediates gap junction closure in astrocytes in response to IL-1beta and hyperosmotic stress; upon activation, p38/SAPK2 translocates from nucleus to cytoplasm; p38 inhibition with SB203580 reverses inhibition of gap junction communication; PKC acts as a distal effector of p38 in this pathway.\",\n      \"method\": \"Pharmacological inhibition (SB203580), immunocytochemistry for p38 localization, dye coupling assay, PKC inhibitor experiments\",\n      \"journal\": \"Glia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional localization assay tied to pathway output, pharmacological tools, single lab\",\n      \"pmids\": [\"15048855\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"VEGFR2 phosphorylation at Tyr1214 is required for VEGF-induced activation of Cdc42 and subsequently SAPK2/p38 and MAPKAP kinase-2, leading to actin remodeling into stress fibers; dominant-negative Cdc42 inhibits SAPK2/p38 activation; RhoA and Rac are not involved in SAPK2/p38-mediated actin reorganization.\",\n      \"method\": \"Site-directed mutagenesis of VEGFR2 Y1214F, dominant-negative/constitutively active Cdc42 constructs, GTPase activity assay, pharmacological inhibition (SB203580), actin staining\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — site-directed mutagenesis of upstream receptor, multiple genetic tools (dominant-negative and constitutively active GTPases), mechanistic pathway placement\",\n      \"pmids\": [\"14724572\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"SAPK2b/p38beta (MAPK11) specifically binds and phosphorylates glycogen synthase at Ser644, Ser652, Thr718 and Ser724 in vitro; p38beta serves as a priming kinase that enables GSK-3 to phosphorylate Ser640 and inhibit glycogen synthase activity; p38beta shows greater affinity for glycogen synthase than p38alpha, p38gamma, or p38delta.\",\n      \"method\": \"In vitro kinase assay, substrate binding assay, phosphopeptide mapping, isoform comparison, co-incubation with GSK-3\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro phosphorylation, phosphosite mapping, priming kinase mechanism demonstrated\",\n      \"pmids\": [\"14680475\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"p38alpha (but not p38beta) promotes Fas-mediated apoptosis by inhibiting phosphorylation and presence of c-FLIPS in DISC to promote caspase-8 activation; both p38alpha and p38beta contribute to mitochondrial Bax localization and inhibition of Bad phosphorylation.\",\n      \"method\": \"Overexpression and translational silencing of p38alpha/p38beta, DISC immunoprecipitation, FACS analysis, caspase activity, western blot\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — isoform-specific genetic approaches, multiple apoptotic pathway readouts, single lab\",\n      \"pmids\": [\"15572410\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"p38beta (MAPK11) knockout mice are viable and show normal p38alpha activation, ERK1/2, JNK, MAPKAP-K2, and MSK1 activation, normal p38-dependent immediate-early gene transcription, normal T-cell development, and normal LPS-induced cytokine production; p38beta is dispensable for inflammatory disease progression in TNFDeltaARE mice, indicating p38alpha is the predominant isoform in immune responses.\",\n      \"method\": \"Genetic knockout, kinase activity assays, cytokine ELISA, TNFDeltaARE cross, disease scoring\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — germline knockout with comprehensive multi-pathway and multi-disease phenotyping\",\n      \"pmids\": [\"16287858\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Spinal p38beta (MAPK11) in microglia (not p38alpha in neurons) mediates tissue injury-induced hyperalgesia; intrathecal antisense knockdown of p38beta but not p38alpha prevents formalin-evoked nocifensive behavior and substance P-induced hyperalgesia, and blocks spinal p38 phosphorylation.\",\n      \"method\": \"Isoform-specific antisense oligonucleotides, behavioral pain assays (formalin, substance P), immunohistochemistry for isoform localization, phospho-p38 western blot\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — isoform-selective genetic knockdown in vivo with behavioral and biochemical readouts\",\n      \"pmids\": [\"15748168\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"p38beta MAPK (MAPK11) mediates CO-induced caveolin-1 expression in smooth muscle cells; p38beta-/- fibroblasts fail to upregulate caveolin-1 in response to CO; p38beta downregulates ERK1/2, which represses caveolin-1 transcription; caveolin-1 is required for the antiproliferative effect of CO.\",\n      \"method\": \"p38beta knockout cells, p38beta gene transfer rescue, CO treatment, ERK1/2 western blot, caveolin-1 expression, cell proliferation assay\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — knockout plus genetic rescue, mechanistic pathway identification, in vivo and in vitro confirmation\",\n      \"pmids\": [\"16051704\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"MAPK11/14 (p38 MAPK) activation is required for EGF-stimulated cytotrophoblast differentiation and syncytium formation; pharmacological inhibition (SB203580/SB202190) blocks spontaneous and EGF-stimulated beta-hCG secretion and cytotrophoblast fusion.\",\n      \"method\": \"Pharmacological inhibition (SB203580, SB202190), beta-hCG ELISA, BrdU proliferation assay, villous explant culture\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological approach with functional readouts, cannot fully distinguish p38alpha from p38beta contribution\",\n      \"pmids\": [\"16120828\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Phosphorylation of VEGFR-2 at Tyr1214 recruits adapter Nck and Src-family kinase Fyn (but not c-Src) to VEGFR-2; Fyn activates PAK-2 and is required for SAPK2/p38 but not FAK activation; this Fyn-Nck-PAK2 complex drives SAPK2/p38 activation, stress fiber formation, and endothelial cell migration.\",\n      \"method\": \"Immunoprecipitation with HA-tagged VEGFR-2 mutants, chemical and dominant-negative inhibitors of Fyn/c-Src, stress fiber staining, migration assays, PAK-2 phosphorylation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — receptor mutants, reciprocal co-IP, multiple genetic/chemical inhibitors, two orthogonal readouts\",\n      \"pmids\": [\"16966330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"p38beta MAPK is required for Ca2+-induced PKCdelta/eta-mediated E2F1 proteasomal degradation during keratinocyte differentiation; dominant-negative p38beta but not p38alpha blocks E2F1 downregulation in this context.\",\n      \"method\": \"Dominant-negative p38beta expression, pharmacological PKC inhibitors, western blot for E2F1, differentiation assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — isoform-specific dominant-negative, single lab, single method for p38beta specificity\",\n      \"pmids\": [\"16116476\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Chemical genetics demonstrates that specific inhibition of p38alpha (not p38beta) is necessary and sufficient for anti-inflammatory efficacy; p38beta knock-in (T106M) mice are resistant to pharmacological p38 inhibition of LPS-induced TNF production; p38beta knockout mice show normal inflammatory responses.\",\n      \"method\": \"Chemical genetics knock-in mice (T106M mutation), p38beta knockout mice, LPS challenge, collagen antibody-induced arthritis model, TNF ELISA\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — two independent genetic approaches (knock-in and knockout) with in vivo disease models\",\n      \"pmids\": [\"17855341\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"p38alpha-PRAK complex localizes to the nucleus while p38beta-PRAK complex localizes exclusively to the cytosol; two residues (Asp145/Leu156 in p38alpha vs. Gly145/Val156 in p38beta) determine the distinct localization; nuclear import (not export) is the determining step; Leu156 of p38alpha interacts with the NLS of PRAK; nuclear localization of PRAK is required for its antiproliferative function.\",\n      \"method\": \"Chimeric and point mutants of p38alpha/p38beta, subcellular fractionation, random mutagenesis, nuclear import assays, co-localization, NIH3T3 proliferation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — mutagenesis identifying specific residues, structural modeling, functional consequence established\",\n      \"pmids\": [\"18268017\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"TGFbeta-induced alpha-smooth muscle cell actin (alphaSMA) expression in renal proximal tubular cells requires p38beta (not p38alpha) MAPK and is mediated via MKK6 (not MKK3); dominant-negative p38beta and dominant-negative MKK6b block TGFbeta-induced alphaSMA; Smad7 and dominant-negative Smad3 also block this effect.\",\n      \"method\": \"Adenoviral expression of dominant-negative p38alpha/p38beta and dominant-negative MKK3/MKK6, western blot for alphaSMA, alphaSMA promoter-luciferase reporter, phospho-specific antibodies\",\n      \"journal\": \"Nephrology, dialysis, transplantation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — isoform-specific dominant-negatives with pathway dissection, single lab\",\n      \"pmids\": [\"18192325\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The crystal structure of human p38beta was determined at 2.05 Å resolution; structural comparison with p38alpha revealed that differences in relative orientation of N- and C-terminal domains reduce the size of the ATP-binding pocket in p38beta compared to p38alpha.\",\n      \"method\": \"X-ray crystallography (PDB: 3gc8, 3gc9 for p38beta C162S and C119S/C162S mutants; 3gc7 for p38alpha C162S)\",\n      \"journal\": \"Acta crystallographica. Section D, Biological crystallography\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — high-resolution crystal structure with functional implications for inhibitor selectivity\",\n      \"pmids\": [\"19622861\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"During hypoxia/reoxygenation in cardiomyocytes, p38alpha phosphorylates p53 at Ser15 leading to mitochondrial p53 translocation and apoptosis; p53 in turn suppresses p38beta activity; estrogen inhibits this p38alpha-p53 axis and preserves p38beta pro-survival activity.\",\n      \"method\": \"Pharmacological inhibition of p38alpha/p38beta, p53 inhibition, ROS measurement, cardiomyocyte apoptosis assays, western blot for phospho-p53, mitochondrial fractionation\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological tools with isoform selectivity, multiple functional readouts, single lab\",\n      \"pmids\": [\"20724307\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"p38alpha and p38beta together are required for mouse embryonic development; combined deletion causes cardiovascular abnormalities at midgestation absent in single knockouts; p38beta cannot fully substitute for p38alpha functions during embryogenesis (assessed by knock-in of p38beta under p38alpha promoter).\",\n      \"method\": \"Double knockout mice, p38beta knock-in under p38alpha promoter, embryonic phenotype analysis, cardiac gene expression analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic models including double KO and knock-in, developmental phenotype with molecular analysis\",\n      \"pmids\": [\"21768366\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"p38beta (MAPK11) promotes phosphorylation of Raptor at Ser863 and Ser771 upon arsenite treatment, thereby activating mTORC1; arsenite induces direct interaction between p38beta and Raptor; this pathway is specific to arsenite and not activated by insulin, nutrients, anisomycin, or H2O2.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, phospho-Raptor western blot, mTORC1 activity assays, stimulus specificity comparison\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro phosphorylation, co-IP demonstrating physical interaction, multiple stimuli controls\",\n      \"pmids\": [\"21757713\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"p38beta activity and STAT pathway are concurrently activated by neuropoietic cytokines (CNTF/LIF) in sympathetic neurons; p38beta overexpression in absence of cytokines stimulates cholinergic marker expression; p38beta-/- neurons show impaired neurotransmitter switch in vitro; stellate ganglion of p38beta-/- mice shows loss of cholinergic properties in vivo.\",\n      \"method\": \"p38beta knockout neurons, p38alpha/p38beta overexpression, dominant-negative p38, cytokine treatment, cholinergic marker expression, in vivo stellate ganglion analysis\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout confirmed in vitro and in vivo, overexpression gain-of-function, isoform specificity established\",\n      \"pmids\": [\"21865449\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"p38beta (MAPK11) specifically phosphorylates C/EBPβ at Thr-188 (a site not phosphorylated by p38alpha), enabling C/EBPβ binding to the atrogin1/MAFbx promoter and upregulating this ubiquitin ligase; C/EBPβ T188A mutant acts as dominant-negative inhibitor of atrogin1/MAFbx upregulation; p38beta-mediated muscle catabolism is abrogated in C/EBPβ-null mice.\",\n      \"method\": \"Tryptic phosphopeptide mapping, ChIP assay, site-directed mutagenesis of C/EBPβ T188A, siRNA knockdown, constitutively active p38alpha/beta expression, C/EBPβ knockout mice, in vivo muscle injection\",\n      \"journal\": \"Skeletal muscle\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — phosphosite mapping, ChIP, mutagenesis, and in vivo knockout all converge on same mechanistic conclusion\",\n      \"pmids\": [\"23046544\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"TGF-beta1 activates p38alpha (proapoptotic) and shifts VEGF signaling from p38beta (prosurvival) to p38alpha in endothelial cells; gene silencing of p38alpha blocks TGF-beta1-induced apoptosis; downregulation of p38beta or p38gamma causes massive apoptosis.\",\n      \"method\": \"Gene silencing (siRNA) of p38 isoforms, apoptosis assays, isoform-specific phosphorylation analysis\",\n      \"journal\": \"Molecular cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — isoform-specific siRNA with multiple apoptotic readouts, single lab\",\n      \"pmids\": [\"22454\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"SOCE-induced AMPK (alpha1 isoform) activates p38beta MAPK, which directly phosphorylates STIM1 on serine residues, inhibiting SOCE (acting as an 'off switch'); knockdown of p38beta (but not other p38 isoforms) prevents PAR-1-mediated STIM1 phosphorylation and potentiates Ca2+ entry.\",\n      \"method\": \"siRNA knockdown of p38 isoforms and AMPKα1, STIM1 phosphorylation assay, Ca2+ entry measurements, permeability assays, AICAR treatment\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — isoform-specific knockdown, direct phosphorylation shown, functional consequence established with multiple approaches\",\n      \"pmids\": [\"23625915\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Integrin-linked kinase (ILK) selectively forms cytoplasmic complexes with p38beta (not other p38 isoforms); ILK knockdown reduces p38beta protein levels post-translationally via the 26S proteasome; ILK-p38beta signaling regulates Hsp27 phosphorylation, actin cytoskeletal organization, and Rac1-dependent bladder cancer cell migration.\",\n      \"method\": \"siRNA knockdown of ILK/p38beta, co-immunoprecipitation, bimolecular fluorescence complementation, proximity ligation assay, proteasome inhibitor rescue (MG132), Hsp27 phosphorylation, migration assay\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP plus orthogonal proximity ligation assay, proteasomal mechanism with rescue, functional consequence\",\n      \"pmids\": [\"23435415\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"p38beta (MAPK11) possesses an intrinsic autophosphorylation activity; a 13-residue region comprising part of the alpha-G helix and MAPK insert triggers this activity; when inserted into p38alpha, this fragment renders it spontaneously active in vitro and in mammalian cells; an interaction between the N-terminus and C-terminal extension suppresses this autophosphorylation in vivo.\",\n      \"method\": \"In vitro autophosphorylation assay, chimeric construct generation, mammalian cell expression, mutagenesis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with mutagenesis, domain-swap experiments confirmed in cells\",\n      \"pmids\": [\"25006254\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"p38beta-mediated p38 activity in breast cancer cells upregulates MCP-1 secretion, which activates osteoclast differentiation and bone resorption; shRNA knockdown of p38beta reduces osteoclast differentiation in vitro and bone destruction in SCID mouse models.\",\n      \"method\": \"shRNA knockdown of p38beta, conditioned media osteoclast differentiation assay, MCP-1 ELISA, SCID mouse bone metastasis model\",\n      \"journal\": \"Biochimie\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockdown with in vitro and in vivo readouts, single lab\",\n      \"pmids\": [\"25066918\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"p38beta MAPK mediates activin A/ActRIIB-induced skeletal muscle catabolism via C/EBPβ activation; siRNA knockdown of p38beta (not p38alpha) abolishes activin A catabolic effects; muscle-specific p38beta knockout mice are protected from activin A-induced muscle catabolism in vivo.\",\n      \"method\": \"siRNA knockdown, muscle-specific p38beta knockout mice, C2C12 myotube atrophy assays, ubiquitin ligase expression, LC3-II western blot, p38 inhibitor (SB202190)\",\n      \"journal\": \"Journal of cachexia, sarcopenia and muscle\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — isoform-specific siRNA and conditional knockout mice with in vitro and in vivo concordance\",\n      \"pmids\": [\"27897407\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"p38beta in mitochondria of cardiomyocytes phosphorylates MnSOD at Thr79 and Ser106; estrogen promotes mitochondrial localization of active p38beta and augments MnSOD activity; point mutation of T79/S106 to alanine abolishes MnSOD antioxidant function; physical interaction between p38beta and MnSOD demonstrated by co-IP.\",\n      \"method\": \"In vitro kinase assay, co-immunoprecipitation, mitochondrial fractionation, point mutagenesis of MnSOD T79A/S106A, MnSOD activity assay, ROS measurement, in vivo I/R model in OVX and ER-null mice\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro kinase assay with phosphosite identification, co-IP, mutagenesis abolishing function, in vivo validation\",\n      \"pmids\": [\"27930699\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"p38beta MAPK self-regulates basal activity through autophosphorylation at multiple sites in its MAPK insert (T241, S261) in addition to the activating T180 site; T241 phosphorylation reduces autophosphorylation in trans; S261 phosphorylation reduces activity of T180-phosphorylated p38beta; T241 is phosphorylated in vivo in bone and muscle tissues and correlates with myogenic differentiation.\",\n      \"method\": \"In vitro autophosphorylation assay, mass spectrometry, site-directed mutagenesis, mammalian cell expression, tissue phosphorylation analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro autophosphorylation with mutagenesis at multiple sites, MS-confirmed sites, in vivo tissue validation\",\n      \"pmids\": [\"26976637\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"MAPK11 (p38beta) is a positive modulator of mutant huntingtin (mHTT) protein levels via its kinase activity; MAPK11 knockout significantly rescues disease-relevant behavioral phenotypes in a knockin HD mouse model; the effect is mHTT-dependent, suggesting a feedback mechanism.\",\n      \"method\": \"MAPK11 knockout mice (HD knockin background), cell-based mHTT level assays, kinase-dead mutant, behavioral phenotyping\",\n      \"journal\": \"Cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout in vivo with behavioral rescue, kinase-activity dependence shown\",\n      \"pmids\": [\"29151587\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"p38beta (MAPK11) mediates GLP-1R agonist exenatide-induced microglial POMC/beta-endorphin expression via a PKA-p38beta-CREB signaling cascade; siRNA knockdown of p38beta (not p38alpha) abolishes exenatide-induced p38 phosphorylation and POMC expression; intrathecal siRNA/p38beta blocks exenatide-induced spinal beta-endorphin expression and mechanical antiallodynia.\",\n      \"method\": \"siRNA isoform-specific knockdown (p38alpha vs. p38beta), intracellular cAMP assay, western blot for p-PKA/p-p38/p-CREB, POMC/beta-endorphin ELISA, intrathecal injection in neuropathic rats\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — isoform-specific genetic knockdown in vitro and in vivo with concordant biochemical and behavioral readouts\",\n      \"pmids\": [\"28202578\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"p38beta MAPK (MAPK11) mediates ULK1-dependent autophagy activation in cachectic skeletal muscle of tumor-bearing mice; p38beta activates transcription factor C/EBPβ to upregulate LC3b and Gabarapl1; p38beta phosphorylates ULK1 at S555; active ULK1 forms a complex with p38beta in myocytes; muscle-specific p38beta knockout abrogates tumor-induced autophagy, UPP activation, and muscle wasting.\",\n      \"method\": \"Muscle-specific p38beta knockout mice, LLC tumor model, ULK1 phosphorylation assays, co-immunoprecipitation (ULK1-p38beta complex), C/EBPβ activation assays, autophagy markers (LC3b, Gabarapl1), p38alpha pharmacological comparison\",\n      \"journal\": \"Cell stress\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional knockout with in vivo tumor model, co-IP demonstrating complex, phosphorylation site identification, multiple pathway readouts\",\n      \"pmids\": [\"31225455\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Upon cancer-induced TLR4 activation in skeletal muscle, p38beta MAPK phosphorylates Ser-12 on p300, stimulating C/EBPβ acetylation and muscle wasting; nilotinib preferentially inhibits p38beta over p38alpha and abrogates this pathway; systemic nilotinib at 0.5 mg/kg/day alleviates muscle wasting and prolongs survival in tumor-bearing mice.\",\n      \"method\": \"Genetic knockdown, p300 phosphorylation assay, C/EBPβ acetylation assay, catabolic gene expression, tumor-bearing mouse model, nilotinib treatment, survival analysis\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — isoform-specific genetic and pharmacological approaches, phosphorylation of specific substrate residue identified, in vivo rescue\",\n      \"pmids\": [\"33355181\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"MAPK11/14 (p38 MAPK) directly phosphorylates SNX27 at Ser51 in response to multiple stressors (starvation, LPS, IL-6, EGF), altering its cargo-binding pocket conformation and reducing interactions with cargo proteins, thereby inhibiting endocytic recycling and promoting receptor lysosomal degradation.\",\n      \"method\": \"Phosphoproteomics, in vitro kinase assay, mutagenesis of SNX27 S51, cargo binding assays, endocytic recycling assays, multiple stress stimuli\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro phosphorylation, mutagenesis of phosphosite, structural consequence (conformation change), functional readout (recycling inhibition)\",\n      \"pmids\": [\"33605979\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"p38beta (MAPK11) is a critical host factor for SARS-CoV-2 replication, functioning at a step after viral mRNA expression; genetic screening, proteomics, and phosphoproteomics identified putative host and viral p38beta substrates in SARS-CoV-2-infected cells; most identified host p38beta substrates have intrinsic antiviral activities.\",\n      \"method\": \"Quantitative genetic screening, genomics, proteomics, phosphoproteomics, multiple cell line validation\",\n      \"journal\": \"mBio\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multi-omic approach with genetic validation, but substrate phosphorylation described as 'putative' without full biochemical validation of individual substrates\",\n      \"pmids\": [\"37345956\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Phosphorylated MAPK11 (p38beta) physically interacts with RUNX2 and sustains RUNX2 protein stability in clear cell renal cell carcinoma cells; P-MAPK11 and RUNX2 co-immunoprecipitate; high RUNX2 expression can neutralize functional degradation of MAPK11; both promote ccRCC cell proliferation and migration.\",\n      \"method\": \"Co-immunoprecipitation, cycloheximide chase assay (RUNX2 half-life), siRNA knockdown, colony formation, EdU assay, transwell migration\",\n      \"journal\": \"Journal of cellular and molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP demonstrating interaction, protein stability assay, single lab\",\n      \"pmids\": [\"37525479\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MAPK11 (p38beta) is a stress- and cytokine-activated MAP kinase with a TGY dual-phosphorylation activation motif that is preferentially activated by MKK6; unlike p38alpha, it possesses intrinsic autophosphorylation activity mediated by its alpha-G helix/MAPK insert region, and self-regulates through additional autophosphorylation at inhibitory sites T241 and S261; it has a distinct substrate specificity from p38alpha—most notably it uniquely phosphorylates C/EBPβ at Thr-188 to drive atrogin1/MAFbx-mediated muscle catabolism, phosphorylates Raptor at Ser863/Ser771 to activate mTORC1 in arsenite-stressed cells, phosphorylates STIM1 to suppress Ca2+ entry, phosphorylates glycogen synthase as a priming kinase for GSK-3, phosphorylates MnSOD at T79/S106 in mitochondria for antioxidant defense, phosphorylates p300 at Ser-12 to drive cancer-induced muscle wasting, and phosphorylates SNX27 at Ser51 to inhibit endocytic recycling; its p38beta-PRAK complex is excluded from the nucleus (unlike p38alpha-PRAK) due to residues Gly145/Val156; it plays pro-survival roles in multiple cell types (mesangial cells, cardiomyocytes, astrocytes, endothelial cells) contrasting with pro-apoptotic p38alpha, promotes cholinergic transdifferentiation of sympathetic neurons, mediates spinal microglial beta-endorphin expression in pain processing, acts as a host dependency factor for SARS-CoV-2 replication, and modulates mutant huntingtin levels in Huntington's disease models.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"MAPK11 (p38beta) is a stress- and cytokine-activated MAP kinase that requires dual phosphorylation of its TGY motif for catalysis and is preferentially activated by MKK6/MEK6, with strong transactivation of substrates such as ATF2 and Sap-1a [#0, #1]. It is distinguished from its paralog p38alpha both structurally and functionally: its crystal structure reveals a constricted ATP-binding pocket relative to p38alpha [#27], and it possesses an intrinsic autophosphorylation activity localized to a 13-residue alpha-G helix/MAPK insert region that is restrained in vivo by an N-terminal/C-terminal interaction and by inhibitory autophosphorylation at T241 and S261 in addition to the activating T180 site [#36, #40]. p38beta executes a distinct substrate program: it acts as a priming kinase that phosphorylates glycogen synthase to enable GSK-3 [#16], phosphorylates Raptor at Ser863/Ser771 to activate mTORC1 selectively under arsenite stress [#30], phosphorylates STIM1 to switch off store-operated Ca2+ entry [#34], phosphorylates mitochondrial MnSOD at Thr79/Ser106 to sustain antioxidant defense [#39], and phosphorylates SNX27 at Ser51 to remodel its cargo pocket and inhibit endocytic recycling [#45]. A dominant theme is its control of skeletal muscle catabolism, where it uniquely phosphorylates C/EBPbeta at Thr-188 to drive atrogin1/MAFbx expression, phosphorylates p300 at Ser-12 to promote C/EBPbeta acetylation, and phosphorylates ULK1 at Ser555 to activate autophagy, collectively mediating activin A-, tumor-, and cachexia-associated muscle wasting [#32, #43, #44]. In contrast to the pro-apoptotic actions of p38alpha, p38beta is broadly pro-survival across mesangial cells, cardiomyocytes, and endothelial cells [#13, #28, #33], and its signaling output is spatially restricted because the p38beta-PRAK complex is excluded from the nucleus via residues Gly145/Val156 [#25]. It also drives HSP27-dependent actin remodeling and migration downstream of VEGFR2 [#9, #22], mediates cholinergic transdifferentiation of sympathetic neurons and spinal microglial beta-endorphin expression in pain processing [#31, #42], modulates mutant huntingtin levels [#41], and serves as a host dependency factor for SARS-CoV-2 replication [#46]. Genetic knockout establishes that p38beta is dispensable for inflammatory cytokine responses, where p38alpha predominates [#18, #24].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established MAPK11 as a bona fide stress-activated MAP kinase with a defined activation requirement and a substrate preference distinct from p38alpha, answering whether the new isoform was catalytically and regulatorily independent.\",\n      \"evidence\": \"In vitro kinase assays, TGY-motif mutagenesis, phosphopeptide mapping and reporter assays defining MKK6 as preferred activator and ATF2/Sap-1a as preferred substrates\",\n      \"pmids\": [\"8663524\", \"9235954\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve in vivo substrate repertoire beyond transcription factors\", \"Physiological context of MKK6 selectivity not addressed\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Placed p38/MAPK11 upstream of MSK1-CREB signaling, linking stress kinase activity to transcriptional output via a downstream effector kinase.\",\n      \"evidence\": \"In vitro reconstitution of MSK1 activation plus SB203580 inhibition in cells, with MSK1 phosphorylating CREB Ser133\",\n      \"pmids\": [\"9687510\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Inhibitor does not distinguish p38alpha from p38beta\", \"Isoform-specific contribution to CREB activation not isolated\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Revealed an isoform divergence in cell-fate control, showing p38beta is pro-survival/anti-apoptotic where p38alpha is pro-apoptotic.\",\n      \"evidence\": \"Isoform overexpression with caspase, nuclear condensation, DNA fragmentation and Bcl-2 rescue assays under Fas/UV challenge\",\n      \"pmids\": [\"9632706\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Overexpression may not reflect endogenous stoichiometry\", \"Molecular substrates mediating survival not identified\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Connected the p38/MAPK11 pathway to cytoskeletal remodeling and migration through HSP27 phosphorylation via MAPKAPK2/3, defining a non-transcriptional output.\",\n      \"evidence\": \"SB203580 inhibition, non-phosphorylatable HSP27 mutants, F-actin staining and migration assays in endothelial cells\",\n      \"pmids\": [\"9832563\", \"10207622\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Pharmacology and pathway summaries do not isolate p38beta from p38alpha\", \"Direct p38beta-HSP27 axis not demonstrated\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Mapped the receptor-proximal pathway driving p38-dependent actin remodeling, identifying VEGFR2 as the specific receptor input.\",\n      \"evidence\": \"VEGFR1/VEGFR2-selective cell lines, neutralizing antibodies, SB203580 and HSP90 rescue with migration assays\",\n      \"pmids\": [\"10744763\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Isoform identity of activated p38 not resolved\", \"Direct kinase-substrate steps downstream of VEGFR2 not fully reconstituted\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Dissected the upstream cascade from VEGFR2-Tyr1214 through Cdc42 to p38, and later through a Fyn-Nck-PAK2 module, establishing how a receptor selectively engages p38-MAPKAPK2 actin signaling.\",\n      \"evidence\": \"VEGFR2 Y1214F mutagenesis, dominant-negative/constitutively active Cdc42, reciprocal co-IP and chemical/dominant-negative Fyn inhibition with stress-fiber and migration readouts\",\n      \"pmids\": [\"14724572\", \"16966330\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"p38beta-specific role within this VEGFR2 cascade not separated from p38alpha\", \"Direct effector phosphorylation by the relevant isoform not shown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identified the first p38beta-preferred metabolic substrate, showing it functions as a priming kinase for GSK-3 on glycogen synthase.\",\n      \"evidence\": \"In vitro kinase and substrate-binding assays, phosphopeptide mapping, isoform affinity comparison and co-incubation with GSK-3\",\n      \"pmids\": [\"14680475\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance to glycogen metabolism not established\", \"Upstream activator in this context not defined\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Genetic knockout resolved the physiological essentiality of MAPK11, showing it is dispensable for inflammation and immune development, with p38alpha predominant.\",\n      \"evidence\": \"Germline p38beta knockout with multi-pathway kinase profiling, cytokine ELISA and TNFDeltaARE disease cross; later corroborated by T106M knock-in chemical genetics\",\n      \"pmids\": [\"16287858\", \"17855341\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Compensation by p38alpha not formally excluded for all phenotypes\", \"Did not address non-immune tissue-specific roles\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Established isoform- and cell-type-specific in vivo functions for MAPK11 in nervous tissue and vascular biology, distinguishing it from p38alpha by selective knockdown.\",\n      \"evidence\": \"Isoform-specific antisense in spinal microglia with pain behavior assays; p38beta knockout/rescue for CO-induced caveolin-1; dominant-negative isoform comparisons\",\n      \"pmids\": [\"15748168\", \"16051704\", \"11500933\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct substrates in microglial pain signaling not identified\", \"Mechanism of CO-induced p38beta activation unresolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Explained the divergent subcellular signaling of the two isoforms by mapping the residues that exclude the p38beta-PRAK complex from the nucleus.\",\n      \"evidence\": \"Chimeric and point mutants (Gly145/Val156 vs Asp145/Leu156), subcellular fractionation, nuclear import assays and proliferation readouts\",\n      \"pmids\": [\"18268017\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Generalizability of cytosolic restriction to other p38beta partners not tested\", \"Consequences for the full p38beta substrate set not mapped\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Provided a structural basis for p38beta's distinct inhibitor and substrate behavior by solving its crystal structure and revealing a reduced ATP pocket.\",\n      \"evidence\": \"X-ray crystallography of p38beta versus p38alpha mutants at 2.05 Angstrom\",\n      \"pmids\": [\"19622861\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of active/phosphorylated state and substrate complexes not determined\", \"Link to autophosphorylation mechanism not yet structural\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Defined developmental and signaling roles, showing p38beta partners with p38alpha for embryonic cardiovascular development and selectively activates mTORC1 via Raptor under arsenite stress.\",\n      \"evidence\": \"Double-knockout and p38beta knock-in mice for development; co-IP and in vitro phosphorylation of Raptor Ser863/Ser771 with stimulus-specificity controls\",\n      \"pmids\": [\"21768366\", \"21757713\", \"21865449\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why arsenite uniquely couples p38beta to Raptor is unclear\", \"Non-redundant developmental substrates of p38beta not identified\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identified the defining p38beta-specific catabolic mechanism in muscle: phosphorylation of C/EBPbeta at Thr-188 to drive atrogin1/MAFbx expression.\",\n      \"evidence\": \"Phosphopeptide mapping, ChIP, C/EBPbeta T188A mutagenesis, siRNA, and C/EBPbeta-null mice with in vivo muscle injection\",\n      \"pmids\": [\"23046544\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream activator of p38beta in catabolic muscle not fully defined here\", \"Did not yet integrate autophagy or acetylation arms\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Expanded the p38beta substrate map to Ca2+ homeostasis and revealed a selective stabilizing partner, showing direct STIM1 phosphorylation and ILK-dependent control of p38beta levels.\",\n      \"evidence\": \"Isoform-specific siRNA with STIM1 phosphorylation and Ca2+ entry assays; reciprocal co-IP, BiFC/PLA and MG132 rescue for ILK-p38beta\",\n      \"pmids\": [\"23625915\", \"23435415\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phosphosites on STIM1 not individually mapped\", \"Mechanism of ILK-mediated p38beta protein protection not detailed\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Resolved the autoregulatory logic of MAPK11, identifying both an activating autophosphorylation element and inhibitory autophosphorylation sites that tune basal activity.\",\n      \"evidence\": \"In vitro autophosphorylation, domain-swap chimeras, mass spectrometry of T241/S261, mutagenesis and tissue phosphorylation analysis\",\n      \"pmids\": [\"25006254\", \"26976637\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream signals that toggle inhibitory autophosphorylation in vivo unknown\", \"Structural basis of the autophosphorylation element not solved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstrated mitochondrial and additional muscle-catabolic functions, placing p38beta inside mitochondria phosphorylating MnSOD and at the center of activin A-induced wasting.\",\n      \"evidence\": \"In vitro kinase and co-IP for MnSOD with T79A/S106A mutants and in vivo I/R models; muscle-specific p38beta knockout and isoform-specific siRNA for activin A catabolism\",\n      \"pmids\": [\"27930699\", \"27897407\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Import mechanism delivering p38beta to mitochondria not defined\", \"Activin A-to-p38beta activation steps incompletely mapped\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Extended p38beta into neurological disease and neuromodulatory signaling, showing it modulates mutant huntingtin levels and drives microglial beta-endorphin via PKA-p38beta-CREB.\",\n      \"evidence\": \"MAPK11 knockout in HD knockin mice with kinase-dead controls and behavioral rescue; isoform-specific siRNA with cAMP, phospho-cascade, POMC ELISA and intrathecal behavioral assays\",\n      \"pmids\": [\"29151587\", \"28202578\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct substrate linking p38beta to mHTT stability not identified\", \"Whether CREB is a direct p38beta substrate in this cascade not shown\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Completed the multi-arm model of cachexia by adding p300 Ser-12 phosphorylation and ULK1-dependent autophagy, and provided a druggable handle via preferential p38beta inhibition.\",\n      \"evidence\": \"Genetic knockdown, p300 phosphorylation and C/EBPbeta acetylation assays, muscle-specific knockout, ULK1 S555 phosphorylation and co-IP, nilotinib treatment with survival analysis\",\n      \"pmids\": [\"33355181\", \"31225455\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of UPP versus autophagy arms not quantified\", \"Off-target effects of nilotinib not fully excluded\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identified a stress-responsive substrate controlling membrane trafficking, showing p38 phosphorylation of SNX27 Ser51 reshapes cargo binding to inhibit endocytic recycling.\",\n      \"evidence\": \"Phosphoproteomics, in vitro kinase assay, SNX27 S51 mutagenesis, cargo-binding and recycling assays across multiple stressors\",\n      \"pmids\": [\"33605979\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative roles of p38alpha versus p38beta on SNX27 not separated\", \"Physiological receptor cargoes most affected not enumerated\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Implicated MAPK11 in viral and oncogenic contexts, defining it as a SARS-CoV-2 host dependency factor and a RUNX2-stabilizing partner in renal carcinoma.\",\n      \"evidence\": \"Genetic screening with multi-omics for SARS-CoV-2; co-IP and cycloheximide-chase RUNX2 stability assays with proliferation/migration readouts in ccRCC\",\n      \"pmids\": [\"37345956\", \"37525479\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"SARS-CoV-2 substrates remain putative without individual biochemical validation\", \"Direct phosphorylation underlying RUNX2 stabilization not demonstrated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How distinct upstream stimuli select among p38beta's many substrates and subcellular pools (nuclear-excluded cytosol, mitochondria, endosomes) to produce divergent pro-survival, catabolic, and trafficking outcomes remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unifying model linking stimulus identity to substrate selection\", \"Mechanism targeting p38beta to mitochondria and other compartments undefined\", \"Structural basis of substrate discrimination versus p38alpha not solved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [0, 16, 30, 32, 34, 39, 44, 45]},\n      {\"term_id\": \"GO:0016740\", \"supporting_discovery_ids\": [0, 1, 16, 30, 39, 45]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 32]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [25, 30, 35]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [10, 14]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [39]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 2, 30, 34]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [5, 8, 36, 45]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [43]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1, 32, 44]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [29, 31]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"MAP2K6\",\n      \"RAPTOR\",\n      \"STIM1\",\n      \"ILK\",\n      \"PRAK\",\n      \"ULK1\",\n      \"SOD2\",\n      \"SNX27\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":{"gene":"MAPK11","tier":"GROUNDING","verdict":"Evidence-grounding concern","subtype":"fabrication","uniprot_band":"rich","rules_fired":"R7","issue":"R7: fabricated (no corpus paper): 22454"},"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}